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(57) ABSTRACT 
The present invention is directed to devices for repair, 
replacement or augmentation of soft tissues in an organism. 
The devices comprise cellular compositions comprising 
cells and preferably, structural proteins such as collagen or 
elastin. The devices can also be used in methods for testing 
the effects of agents on soft tissues. 
15 Claims, 37 Drawing Sheets 
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TUBULAR CONSTRUCT FOR 
IMPLANTATION 
RELATED APPLICATIONS 
This application claims priority to Provisional Applica-
tion Ser. No. 60/289,961 filed on May 10, 2001. 
FIELD OF THE INVENTION 
The present invention relates to devices made from com-
binations of biological materials and methods of making and 
using such devices. In general, the present invention relates 
to methods of making soft tissue medical devices for uses in 
repair of damaged tissues and therapeutic agent determina-
tions. 
BACKGROUND OF THE INVENTION 
In the United States alone, surgeons perform approxi-
mately 600,000 by-pass operations every year to provide 
repair to diseased arteries and restore blood flow to the heart. 
While autologous saphenous veins and internal mammary 
arteries have typically been utilized as conduits for these 
operations, there are a number of complications associated 
with these grafts. One complication arises when the patient 
cannot provide autologous tissues. The symptoms of vascu-
lar disease are frequently systemic causing many of these 
periphery vessels to be unsuitable for vascular replacement. 
Even when they are usable, donor site pain and morbidity 
complicate the operation. Furthermore, these grafts often 
slowly occlude due to intimal hyperplasia necessitating 
subsequent surgical interventions. 
2 
scaffold material to create a prosthesis capable of mimicking 
the function of native soft tissue. 
A preferred embodiment of the present invention com-
prises methods to make hybrid material, small diameter 
tissue engineered devices such as blood vessels. A preferred 
blood vessel device comprises an isolated elastin scaffold 
support structure and a cellular composition comprising a 
protein gel composition such as collagen or fibrin, or mix-
tures thereof, and cells. Another preferred embodiment 
10 comprises a support structure and a cellular composition of 
protein gel composition wherein the cells have been altered. 
Alterations include transfection and expression of DNA 
constructs, for example, to provide proteins. The devices 
may also comprise agents that have effects on the device or 
15 the environment or that provide detection capability to the 
device. 
Devices of the present invention can be made using 
synthetic or natural materials, or combinations of natural 
and synthetic materials. The natural materials can be pro-
20 vided by the same individual in whom the device will be 
used, or can be provided by others of the same or different 
species. The materials used in the devices may also be 
derived or altered using molecular biological techniques, 
such as gene manipulation, cloning, gene therapy or other 
25 methods known to those skilled in the art. 
Methods of using the soft tissue devices of the present 
invention comprise methods for treatment of pathologies or 
disease states of soft tissues, found in organisms such as 
humans or animals. In particular, there are many applica-
30 tions for treatments of cardiovascular disease, such as coro-
nary artery bypass and other small diameter vascular 
replacement procedures. Repair or replacement of any soft 
tissues is contemplated by the present invention including, 
Ten to twenty percent of coronary artery by-pass patients 
require a second operation within ten years, and frequently 35 
even patients who could provide vessels initially do not have 
adequate vessels for follow-up operations. Although a num-
ber of attempts have been made to develop a synthetic 
small-caliber vessel, the demanding, low flow environment 
but not limited to, bladder, lungs and vocal cords. 
Other methods of using the devices of the present inven-
tion comprise using the device in a controlled environment 
as an assay system for determining the effects of agents on 
biological tissues. Use of the devices in an environment can 
also be for determinations of in situ measurements of the 
of the vasculature typically leads to thrombosis and occlu-
sion shortly after implantation. 
Soft tissue injuries or pathological conditions are often 
hard to treat because replacement tissues are not available or 
by adding a rigid member device to the soft tissue area only 
creates a more dysfunctional organ. For example, damaged 
lung tissue is generally not repaired, but is excised by 
surgery. Addition of a rigid material to the lung, in an effort 
40 environment. For example, implantation of a vascular device 
can be used to determine the hemodynamic effects on 
vessels in healthy or pathological states. Additionally, the 
devices of the present invention can be used to provide 
agents to soft tissue structures. For example, a device 
to repair the lung would only further comprise the lung and 
gas exchange functions. 
45 implanted in the bladder could provide both tissue repair and 
through controlled release, provide therapeutic agents to 
prevent the growth of cancerous cells or attachment of 
bacteria. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is graph showing gel compaction in HDF con-
structs. 
What is needed are devices that are capable of providing 50 
repair for soft tissues. Ideally, these devices would be 
immune-compatible alternatives to autologous tissues, pos-
sess suitable properties for surgical implantation, and func-
tion in the native environment of the repaired soft tissue. 
Additionally, what is needed are devices that mimic soft 
tissue that can be used, either in vivo or in vitro, in testing 
agents to determine the agents effects on native soft tissue. 
Such devices can be used for diagnostic or therapeutic 
purposes, as can agents that are determined to be effective. 
FIG. 2 is a chart showing wall thicknesses of HDF 
55 constructs. 
FIG. 3 is a graph showing compaction in RASM con-
structs. 
FIG. 4 is a chart showing wall thicknesses of RASM 
60 
constructs. 
SUMMARY OF THE INVENTION 
The present invention comprises devices that are capable 
of being used in soft tissue environments. In particular, the 
devices comprise a support structure in combination with a 65 
cellular composition. For example, methods of making such 
a device comprise combining compositions of cells with a 
FIG. 5 is a chart showing ultimate tensile stresses ofHDF 
constructs. 
FIG. 6 is a chart linear moduli of HDF constructs. 
FIG. 7 is a chart showing ultimate tensile stresses of 
RASM constructs. 
FIG. 8 is a chart showing linear moduli of RASM 
constructs. 
US 7,029,689 B2 
3 
FIG. 9 is a chart showing yield energies of HDF con-
structs. 
FIG. 10 is a chart showing failure energies of HDF 
constructs. 
FIG. 11 is a chart showing failure/yield energy ratios of 
HDF constructs. 
FIG. 12 is a chart showing yield energies of HDF con-
structs. 
FIG. 13 is a chart showing failure energies of HDF 
constructs. 
FIG. 14 is a chart showing failure/yield energy ratios of 
HDF constructs. 
FIG. 15 is a graph showing characteristic creep profiles. 
FIGS. 16A-D are charts showing Burger's Model Param-
eters of HDF constructs. 
FIGS. 17A-D are charts showing Burger's Model Param-
eters of RASM constructs. 
FIG. 18 is a graph showing relaxation profiles of con-
structs. 
FIG. 19 is a chart showing initial moduli of HDF con-
tructs. 
FIG. 20 1s a chart showing relaxed moduli of HDF 
constructs. 
FIG. 21 1s a chart showing initial moduli of RASM 
contructs. 
FIG. 22 is a chart showing relaxed moduli of RASM 
constructs. 
FIG. 23 is a chart showing initial/relaxed ratios of HDF 
constructs. 
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used as vascular implants. The invention is in no way to be 
limited to such compositions, devices or methods of use, but 
is provided for illustrative purposes. It is contemplated by 
the present invention that soft tissue devices can be made 
using biological materials found in any type of soft tissue of 
living organisms and may or may not use cells derived from 
that particular soft tissue. Nonlimiting examples of soft 
tissues of living organisms include integument tissues other 
than hard bone, skin, membranes, mucosa! membranes, 
10 organ linings or coverings such a meninges, periodontal 
material such as gum tissue, vocal cords, organs such as 
bladders, including but not limited to urinary or gall bladder, 
diaphragm, blood vessels, including large vessels to capil-
laries. It is contemplated that the devices of the present 
15 invention be used to repair or replace damaged tissues, and 
also that structures not normally found in the living organ-
ism be provided to add function or repair to the body. For 
example, if the urinary bladder of an organism is too 
diseased or damaged from trauma to be repaired by adding 
20 devices of the present invention to that organ, it is contem-
plated that repair also include providing a separate soft 
tissue device of the present invention that provides bladder 
function that works with or instead of the original bladder. 
The organism would then have two bladders, the minimally 
25 functioning original bladder and bladder functions provided 
by the soft tissue device. Additionally, the original organ's 
functions may be entirely replaced by the soft tissue devices 
of the present invention. 
FIG. 24 is a chart showing initial/relaxed ratios ofRASM 30 
In general, the soft tissue devices of the present invention 
are living grafts that consist of biological materials and 
provide several benefits. The grafts interact with the physi-
ological environment to elicit regenerative wound healing 
responses and to evoke both short-term and long-term 
remodeling adaptations. In vascular devices or grafts, the 
constructs. 
FIGS. 25A-D are charts showing Burger's Model param-
eters of HDF constructs. 
FIGS. 26A-D are charts showing Burger's Model param-
eters of RASM constructs. 
FIG. 27 is a graphic illustration of pIRES-lneo plasmid. 
FIG. 28 is a schematic of the construction of pIRES-
elastin plasmid. 
FIG. 29 is a schematic of the incorporation oftropoelastin 
cDNA into pIRES-lneo. 
FIG. 30 is a chart showing tropoelastin mRNA expres-
s10n. 
FIG. 31 is a chart showing the gel compaction of disk 
constructs. 
FIG. 32 is a chart showing the gel compaction of disk 
constructs containing HDFs. 
FIG. 33 is a graph of tropoelastin mRNA expression. 
DETAILED DESCRIPTION 
The present invention is directed to devices derived from 
biological materials for replacement of repair of tissues 
found in living organisms. Preferably, the devices have the 
mechanical, bioactive and biocompatible properties similar 
35 potential for low thrombogenicity properties allows these 
grafts to replace small diameter vessels and maintain 
patency in areas of low and even oscillatory blood velocity. 
When composed of autologous tissue, the soft tissue devices 
elicit a more mild immune reaction than that observed in the 
40 foreign body responses associated with other types 
implanted devices. Living devices or grafts also exhibit 
bioactivity and resistance to infection. 
In addition to providing replacement and repair functions 
for living organisms, the present invention can also be used 
45 a living laboratory for studying physiological parameters 
and for identifying agents that effect soft tissues. As an 
example of vascular studies, a soft tissue device may provide 
scientists with a controlled system which could be used to 
study hemodynamics, atherosclerosis, and other cardiovas-
50 cular pathologies. Agents can be administered to such soft 
tissue devices, incorporating cells and materials found in 
tissues of living organisms, to determine the effects of the 
agents on such tissues. The agents are administered to the 
devices in vitro or in vivo environments. 
Many approaches to tissue engineering biological implant 
devices have focused on collagen-based strategies as col-
lagen induces minimal immunological responses and sus-
tains a majority of the mechanical load in many tissues. 
While these devices exhibit many desirable characteristics, 
to the tissue being repaired or replaced. The present inven- 55 
tion comprises soft tissue devices comprising a natural or 
synthetic support structure and cells. The present invention 
also comprises compositions for making the support struc-
tures and for treatment or maintenance of the cells. It is 
preferred that the devices comprise compositions of living 
cells so that cellular activities, such as remodeling of incor-
porated materials, continue in the device. In this sense, the 
soft tissue devices of the present invention are considered to 
60 they typically possess inadequate mechanical properties for 
implantation. 
Although there are many properties that are desired in a 
successful soft tissue device, one to be considered is the 
mechanical properties of the device. For example, if a 
65 vascular soft tissue device is unable to withstand large 
interluminal pressures and harsh shear environment, it will 
ultimately fail. Likewise, a vascular soft tissue device is 
be living tissue or alive, and thus, can function more like 
tissue found in a living organism. 
Much of the description focuses on compositions and 
methods for making and using soft tissue devices that are 
US 7,029,689 B2 
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unsuitable for implantation if it is unable to withstand the 
millions of cyclic pulses that it encounters during its life-
time. Structural integrity, elasticity, and durability are char-
acteristics to be considered in provided an adequate implant 
or replacement soft tissue device. 
Significant efforts have been made to identify stimuli, 
such as cyclic stretching and ribose-mediated glycation, to 
augment the strengths of prior art collagen-based vascular 
grafts. Despite some favorable findings, the prior art grafts 
still possessed little elasticity and extensive development 10 
periods are required for many of these stimuli to take effect. 
These prior art collagen grafts did not include other biologi-
cal materials found in soft tissues, such as elastin. Patho-
logical conditions in living bodies result from elastin defi-
ciencies such as aneurysms and other pathological vascular 15 
conditions. 
In addition to collagen, elastin plays a major role in 
determining mechanical performance of native vessels. 
Elastin fibers can extend 50--70% under physiological loads, 
and depending on the location of the vessel, elastin content 20 
can range from 33-200% that of collagen. In spite of its role 
in maintaining proper vessel function, elastin had not been 
successfully used in vascular graft matrices prior to the 
present invention. Furthermore, the majority of attempts to 
assay for elastin production from cells in non-elastin-based 25 
grafts had detected little to no elastin. 
Devices of the present invention preferably contain mate-
rials that provide functional and/or mechanical characteris-
tics that mimic or at least are an adequate replacement for 
the original tissue found in the living organism. These 30 
materials may be naturally found in the original tissue or 
may be materials found in other tissues that provide 
adequate functional and/or mechanical characteristics for 
the tissue to be treated, replaced or studied. For the vascular 
soft tissue devices provided as illustration below, elastin is 35 
a material that provides functional and/or mechanical char-
acteristics to the soft tissue device that is an adequate 
replacement for the original vascular tissue. In these 
examples, elastin that is naturally found in vascular tissue is 
provided in some embodiments and elastin that is provided 40 
from artificial sources is provided in other embodiments. In 
soft tissue devices used for other body tissues, the same or 
different materials can be provided as elastin is provided in 
these vascular embodiments. 
A preferred embodiment of the present invention com- 45 
prises a soft tissue device comprising a support structure and 
exogenous elastin proteins, fragments or combinations of 
proteins and fragments. Methods comprising addition of 
fragments of elastin into soft tissue devices provide high 
degrees of flexibility in the fabrication processes. By allow- 50 
ing the elastin to be added along with the other ECM 
(extracellular matrix) proteins, it is possible to control both 
the amount of protein inserted and the overall dimensions of 
the devices. 
6 
material as the scaffold material, and the cells. In other 
embodiments described herein, the scaffold material is a 
natural or synthetic support structure, such as an elastin 
scaffold, and the cellular composition comprises collagen, 
elastin or similar material and cells. 
The methods of making these exogenous elastin devices 
comprise methods of incorporating elastin into collagen-
based vascular grafts. These methods are allowfor the 
amount and type of elastin incorporated to be easily adjusted 
and the methods can be modified to make other embodi-
ments of soft tissue devices. 
Soft tissue devices comprising exogenous elastins can be 
made in any desired shape necessary to provide for the 
repair, replacement or investigation. For example, in vascu-
lar devices, tubular shapes are preferred. In general, a 
vascular device comprises tubular-shaped devices seeded 
with HDFs and cultured as shown in Example 3. Gel 
compaction, histological staining, and mechanical testing 
can be conducted to determine if the device has the needed 
characteristics. 
Any type of exogenous elastin can be added to the support 
structure composition. Elastin that is insoluble, soluble, 
peptides or fragments of elastin can be used. The elastin can 
be purified by methods known to those skilled in the art, 
including but not limited to, neutral extraction, alkaline 
extraction, or through non-degradative processes. Enzymes 
or proteases such as elastase can be used to form peptides or 
peptides can be formed through mechanical or chemical 
methods. Exogenous elastin can be added in any amount 
necessary to provide the needed mechanical or functional 
characteristics. Ranges of elastin concentration in the device 
comprise 0.0001 mg/ml to 50 mg/ml, preferably 0.001 to 50 
mg/ml, more preferably 0.01 to 25 mg/ml, and most pref-
erably 0.1 to 20 mg/ml. The amounts of collagen or other 
base material can be constant or can vary. The amount of 
collagen used can range from 0.0001 mg/ml to 50 mg/ml, 
preferably 0.001 to 50 mg/ml, more preferably 0.01 to 25 
mg/ml, and most preferably 0.1 to 20 mg/ml. The cell type 
and initial concentration of cells added is determined by the 
type of device and function thereof. The concentrations of 
cells added as an initial amount to the cell composition range 
from 0.001xl06 cells/ml to 100xl06 cells/ml, preferably 
0.01xl0
6 
cells/ml to 50xl06 cells/ml, more preferably O.Olx 
106 cells/ml to 10xl06 cells/ml, most preferably, 1.0xl06 
cells/ml. 
Other embodiments contemplated by the present inven-
tion comprise chemical modifications of the elastin particles. 
Chemical domains, such as the fibronectin RGD amino acid 
binding sequence, induce cell-matrix binding. Once attached 
to the elastin fragments, the cells deposit their secreted ECM 
to form a functional network between the elastin compo-
nents. Other embodiments comprise the introduction of 
crosslinking sequences which could then directly link the 
elastin fragments with the surrounding ECM. Rabaud et al. 
The exogenous elastins are added to the support structure 
compositions comprising the base material, such as col-
lagen, and cells. An example how to make a support struc-
ture comprising collagen and cells is given in Example 2. In 
general, in making a support structure, collagen composi-
tions are mixed with a desired cell population, which may be 
homogeneous or a heterogeneous cell population, i.e., the 
same or different types of cells, and allowed to form the 
desired shape. In these embodiments, collagen functions as 
55 have patented an elastin-based product which covalently 
binds elastin to fibrin monomers in artificial biomaterial 
support structures (Rabaud, Lefebure Clement et al. 1993). 
an initial or base structural material, but it is contemplated 
that any natural or synthetic material can provide this initial 
or base structural material. In these embodiments, the cel-
lular composition comprises collagen, elastin or similar 
Though not wishing to be bound by any particular theory, 
it is theorized that following incorporation into collagen-
60 based gels, the cells quickly remodel their surrounding 
matrices. It has been found in some embodiments, that 
incorporation of elastin fragments into the devices affects 
the degree of matrix compaction attained by the cells. In 
many embodiments, devices comprising exogenous elastin 
65 are thicker or have more bulk than similarly shaped devices 
without elastin. It is preferred that some cells incorporated 
in the devices remain alive, in a range of about greater than 
US 7,029,689 B2 
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10%, preferably greater than 25%, more preferably greater 
than 45%, most preferably greater than 51 %. Histological 
and immunofluorescent staining, live-dead analyses and 
total DNA assays or other methods known to those skilled in 
the art are used to characterize the cells or other components 
in the devices and determine the viability of the cells. 
Mechanical tests, such as uniaxial tensile testing, ultimate 
stresses and linar moduli parameters, yield and failure 
energies, and other tests known to those skilled in the art can 
be used to determine the mechanical characteristics of the 10 
devices. 
8 
uniaxial tensile testing, ultimate stresses and linar moduli 
parameters, yield and failure energies, and other tests known 
to those skilled in the art can be used to determine the 
mechanical characteristics of the devices. 
A preferred embodiment comprises a soft tissue device 
comprising an isolated elastin scaffold that has been incu-
bated with a composition comprising collagen, 2 mg/ml and 
1xl06 HDF cells or RASM (rat aortic smooth muscle) cells. 
A method for making such a device is taught in Example 4. 
Alternatively, the scaffold may be provided by a synthetic 
or manufactured structure, which would eliminate calcifi-
cation or immunogenic problems. The synthetic structure 
may be made of natural or synthetic materials. A preferred 
soft tissue device comprises a synthetic structure made of 
A preferred embodiment of the present invention com-
prises a composition comprising collagen, 2 mg/ml, exog-
enous elastin, 2 mg/ml, and HDF cells, lxl06 cells/ml. 
Methods for making such a composition is found in the 
Examples. The composition can be formed into any desired 
shape for use in repair, replacement and as an assay material. 
A preferred embodiment of the present invention com-
prises devices comprising isolated natural scaffold materials 
15 Dacron that has been incubated with a composition com-
prising collagen and HDF cells or RASM cells. Further, the 
scaffold may be provided by collagen sleeves as described in 
Example 9. Such structures may have cross-linked compo-
nents for further structural integrity. Methods of cross-
or synthetic scaffold materials that mimic the characteristics 20 linking materials is known in the art and includes treatments 
with glutaraldehyde, DHT and irridiation. of natural scaffolds. For example, a soft tissue vascular 
embodiment comprises isolation of intact elastin scaffolds 
from porcine carotid arteries. These scaffolds are combined 
with collagen gels and cells to provide hybrid elastin scaf-
fold devices. By providing natural elastin scaffolds, a known 25 
quantity of elastic material is used, the fibers of the isolated 
scaffolds are organized and connected into functional struc-
tures as they would be in native arteries. While variability 
between donor animals produces slightly less control in 
terms of regulating the quantity and quality of the elastic 30 
scaffold, the mechanical performance characteristics are 
desirable for some applications. Additionally, these embodi-
ments do not require cells to reorganize molecules or pro-
teins to form the structure. Any shaped natural or synthetic 
scaffold is contemplated by the present device. 
In yet another embodiment, the cellular composition 
comprises cells that have been modified or altered. A pre-
ferred modification is the transfection of the cells with 
recombinant DNA. Such transfection occurs by methods 
known to those skilled in the art using vectors of known 
types. Preferably, the expression products of such vectors 
include, but are not limited to, structural proteins, peptides 
or fragments such as elastin, collagen, fibrin, or ECM 
elements. In preferred embodiments, NIH/3T3 cells or pri-
mary human fibroblasts were transfected with DNA vectors 
comprising human tropoelastin cDNA which was under the 
control of the cytomegalovirus promoter. These cells can be 
used in addition to or as replacement for the embodiments of 
In a preferred method, natural elastin structures, such as 
arterial tissue, are isolated from an organism. An example of 
35 the devices described herein. It is further preferred that the 
cellular compositions comprising altered or modified cells 
comprise environmental factors, for example, that that help 
direct the formation of appropriate structures by the 
expressed proteins. For example, elastin fibers are found in 
an isolation procedure is shown in Example 4, and such 
methods are known to those skilled in the art. The isolated 
natural structure is added to a cellular composition. Prefer-
ably, this cellular composition comprises one or more cell 
types. More preferably, the composition comprises one or 
more cell types and matrix materials such as collagen, fibrin, 
elastin, extracellular matrix materials or mixtures and com-
binations of matrix materials or fragments, polymers and 
peptides thereof. Ranges of collagen, elastin, fibrin or other 
base material can be constant or can vary and can include 
mixtures of several types of materials, including fragments, 
polymers, peptides, or modified fragments, polymers or 
peptides. The amount of these materials used can range from 50 
0.0001 mg/ml to 50 mg/ml, preferably 0.001 to 50 mg/ml, 
more preferably 0.01 to 25 mg/ml, and most preferably 0.1 
40 a number of tissues throughout the body, but the structure 
and influence of the fibers differ significantly depending 
upon the specific location (Cleary and Gibson 1996). Con-
centric lamellar rings of elastic fibers are found in arteries, 
whereas elastic fibers in ligaments appear as solid, branch-
45 ing rod-like structures. In the cartilage of the ear and larynx, 
they appear as a mesh network of fine fibrils. Other tissues, 
such as the skin and the lungs, possess combinations of these 
structures. 
to 20 mg/ml. The cell type and initial concentration of cells 
added is determined by the type of device and function 
thereof. The concentrations of cells added as an initial 55 
amount to the cell composition range from 0.001xl06 cells/ 
ml to 100xl06 cells/ml, preferably 0.01xl06 cells/ml to 
50xl0
6 
cells/ml, more preferably O.Olxl06 cells/ml to 
10xl0
6 
cells/ml, most preferably, 1.0xl06 cells/ml. It is 
preferred that some cells incorporated in the devices remain 60 
alive, in a range of about greater than 10%, preferably 
greater than 25%, more preferably greater than 45%, most 
preferably greater than 51 %. Histological and immunofluo-
rescent staining, live-dead analyses and total DNA assays or 
other methods known to those skilled in the art are used to 65 
characterize the cells or other components in the devices and 
determine the viability of the cells. Mechanical tests, such as 
During development, each of these tissues is exposed to 
a different environment where mechanical and biochemical 
cues direct the synthesis of the elastic fibers and other matrix 
components. Mechanical conditioning and other methods 
which induce circumferential aligriment may also help to 
direct the assembly of elastic fibers towards the desired 
lamellar ring architecture. In the methods of making the 
devices comprising cellular compositions comprising 
altered or modified cells, it is also preferred that such 
methods comprise steps for simulating environmental con-
ditions. For example, organization of expressed proteins 
may require a pulsatile mechanical motion for correct struc-
tural alignment of the fibers. 
It is preferable that the modified or altered cells be capable 
of regulation so as to turn on or off the transcription, 
translation or expression of the exogenous DNA. Once 
sufficient quantities of the products of the exogenous DNA 
have been produced, it is preferable to down regulate or shut 
off recombinant expression. Failure to do so may result in a 
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pathological state. In the case of recombinant expression, 
there are various methods that could be utilized to regulate 
production. For example, inducible plasmid systems could 
be employed to turn mRNA synthesis on and off based on 
chemical signals. The pMAM-neo vector uses a dexametha-
sone regulated MMTV promoter to control expression of 
target genes. Similarly, the Tet-on and Tet-off vectors are 
two alternative commercially available systems which have 
been reported to have high-level, regulated gene expression 
in response to varying concentrations of tetracycline 
(Clonetech, Palo Alto, Calif.). 
A second method involves the use of a kill gene. Specific 
kill signals have been developed and can be engineered into 
the genetic makeup of recombinant cells. Once triggered, 
these systems will direct the transfected cells down the 
apoptotic pathway leading to cell death. After sufficient 
quantities of the expression product have been deposited 
into the vascular constructs, these kill systems could be 
employed. 
10 
be any compound, chemical, therapeutic agent, pharmaceu-
tical agent, drug, biological factors, fragments of biological 
molecules such as antibodies, proteins, lipids, nucleic acids 
or carbohydrates; nucleic acids, antibodies, proteins, lipids, 
nutrients, cofactors, nutriceuticals, anesthetic, detection 
agents or an agent that has an effect in the body. Such 
detection and therapeutic agents and their activities are 
known to those of ordinary skill in the art. 
This invention is further illustrated by the following 
10 examples, which are not to be construed in any way as 
imposing limitations upon the scope thereof. On the con-
trary, it is to be clearly understood that resort may be had to 
various other embodiments, modifications, and equivalents 
thereof which, after reading the description herein, may 
15 suggest themselves to those skilled in the art without depart-
ing from the spirit of the present invention and/or the scope 
of the appended claims. 
The articles and patents cited herein and in the priority 
application, and the priority application, are herein incorpo-
20 rated in their entireties. Another method utilizes the natural down regulation of 
recombinant transcripts. When cells are transiently trans-
fected with plasmid expression systems, the majority of 
recombinant DNA exists in the nucleus in the form of 
plasmids. As the cells divide, perfect replication and distri-
bution of these plasmids to the progeny does not occur. 25 
Since unmodified cells typically divide quicker than their 
genetically altered counterparts, transfected cells are gradu-
ally overgrown and the level of recombinant expression 
drops. Even in the case of retroviral delivery systems, 
reduction in transcript production may occur over time. By 30 
timing the expression loss with the desired accumulation of 





Several types of eukaryotic cells, including neonatal 
human dermal fibroblasts (HDFs), the murine NIH-3T3 
fibroblast cell line, and rat aortic smooth muscle cells 
(RAS Ms) were used to investigate the effects of elastin in 
vascular grafts. All eukaryotic cells were cultured and main-
tained under sterile conditions in tissue culture treated dishes 
and T-flasks. Media changes, subculturing, and other 
manipulations were conducted in laminar flow Class IIA/B3 The present invention also contemplates cellular compo-
sitions comprising cells that normally express structural 
proteins or other desired products. For example, de nova 
elastin production could also be achieved using non-recom-
binant means. Various cell types such as bovine ligament 
fibroblasts (BLFs) and bovine ear chondrocytes have been 
shown to produce notable quantities of tropoelastin in cul-
ture. The tropoelastin from the ligament fibroblasts typically 
remains in its soluble form in the culture media while much 
of the elastin from the ear chondrocytes has been found to 
become incorporated into the extracellular matrix. Further 
methods comprise addition of growth factors and nutrient 
supplements for an upregulation of elastin production in 
cells. Insulin-like growth factor-I (IGF-1) (Rich, Ewton et 
al. 1992) and transforming growth factor-~! (TGF-~1) (Ka-
hari, Olsen et al. 1992) induce an upregulation in elastin 
expression of cultured cells. Copper ions are necessary for 
proper lysyl oxidase activity and crosslinking of the elastin 
fibers. 
The devices and compositions of the present invention 
may optionally comprise one or more agents. The agents 
may be biologically active agents that can be used in 
therapeutic applications or the agents may be agents that are 
useful in detection methods. In preferred embodiments, one 
or more agents are incorporated into the scaffold structure or 
alternatively, incorporated in the cellular composition. For 
example, a device of the present invention may incorporate 
an opaque substance so that after implantation to device can 
35 biological safety cabinets (Forma Scientific, Marietta, 
Ohio). Unless indicated, cells were maintained at 5% C02 
and 37° C. in humidified, water-jacketed incubators (Forma 
Scientific). 
Cell culture medium was selected based on the needs of 
40 individual cell types and was replaced every 2-3 days to 
replenish nutrients and to remove waste products. When 
cultures became 90--95% confluent cells were trypsinized 
and split. Following a brief rinse in Hank's Buffered Salt 
Solution (HBSS) or 0.05% trypsin-0.53 mM ethylenedi-
45 aminetetracetic acid (EDTA) in HBSS (Mediatech, Hern-
don, Va.) to remove ca++ ions and serum proteins, the cells 
were incubated with approximately 50 µl of 0.25% trypsin-
0.53 mM EDTA in HBSS (Mediatech) per cm of growth area 
at 37° C. for 2-4 minutes. The flasks were tapped lightly and 
50 examined under an inverted microscope to ensure that the 
cells had detached. The trypsin-EDTA was neutralized with 
excess complete culture media (at least three times the 
trypsin solution volume). Unless otherwise indicated, cell 
suspensions produced by trypsinization were typically sub-
55 cultured using 1 :3 to 1 :4 split ratios, incorporated into 3-D 
constructs, or frozen down for cryopreservation. 
Cell populations were assessed using either a hemacy-
tometer or a Coulter Multisizer II cell counter (Beckman 
Coulter, Fullerton, Calif.). Long-term storage of cells was 
60 performed using liquid nitrogen cryopreservation. 
be monitored with noninvasive methods. Agents for treat-
ments of biological conditions, including, but not limited to, 
chronic and acute diseases, maintenance and control of the 
immune system and other biological systems, infectious 65 
diseases, vaccinations, and hormonal maintenance and con-
trol. The agents contemplated by the present invention can 
Human Dermal Fibroblasts (HDFs) 
Passage one normal neonatal HDFs were purchased from 
Clonetics-Biowhittaker, Inc. (Walkersville, Md.). They 
arrived frozen in screw cap cryovials (-500,000 cells/vial) 
and were stored under liquid nitrogen until ready for use. 
Prior to purchase, the manufacturer performed safety studies 
US 7,029,689 B2 
11 
to screen for HIV-1, hepatitis-B and hepatitis-C and char-
acterization studies to ensure a negative expression of Von 
Wille brand factor, cytokeratins 18 & 19, and smooth muscle 
alpha-actin. Supplementary descriptions outlining the cell 
isolation and characterization methods are available on the 
Clonetics web site. 
As recommended by the supplier, the cells were subcul-
tured twice using a 3,500 cells/cm2 seeding density and 
preserved in liquid nitrogen storage. At the point of conflu-
ency Gust before harvest), HDFs typically reached a density 
of 30-40,000 cells/cm2 . The cells were grown in either a 
fibroblast-specific growth medium with a series of growth 
factor supplements supplied by Clonetics, or an alternative 
media formulation Dulbecco's Modified Eagle's Media 
(DMEM) (Mediatech, #10-017-CM) containing glucose ( 4.5 
g/L), L-glutamine (4 mM) was supplemented with 10% 
Fetal Bovine Serum (FBS) (Sigma), penicillin (100 IU/ml), 
and streptomycin (100 µg/ml) and used to culture the cells. 
Experiments involving HDFs were conducted between pas-
sages five and eight. 
NIH/3T3 Fibroblasts 
The NIH/3T3 murine fibroblast cell line was originally 
obtained from American Type Culture Collection (ATCC) 
(Manassas, Va.). The adherent, highly contact-inhibited cells 
were established from NIH Swiss mouse embryo cultures 
using the same techniques as the original randomly bred 
3T3s. 
Cells were cultured at 10% C02 , 37° C. using DMEM 
containing glucose (4.5 g/L), L-glutamine (4 mM), 10% 
FBS, penicillin (100 IU/ml), and streptomycin (100 µg/ml). 
At the point of confluency Gust prior to subculturing), the 
NIH/3T3's typically reached a density of 100,000 cells/cm2 . 
Experiments involving NIH/3T3's were conducted any-
where from passage four to passage seventeen. 
Rat Aortic Smooth Muscle Cells (RASMs) 
RASMs were isolated from the thoracic aortas of male 
Sprague-Dawley rats (-350 g). They were cultured to pas-
sage two and frozen in DMEM+40% FBS+10% DMSO 
cryopreservation media. Upon thawing, the RASMs were 
cultured at 10% C02 , 37° C. using DMEM containing 
glucose (4.5 g/L), L-glutamine (0.584 g/L), 10% FBS, 
penicillin (100 IU/ml), and streptomycin (100 µg/ml). At the 
point of confluency, RASMs typically reached a density of 
150,000 cells/cm2 . Experiments involving RASMs were 
conducted between passages six and nine. 
Example 2 
A Collagen Support Structure 
The use of reconstituted collagen as a cell scaffold was 
first described by Bell et al. in 1979 (Bell, Ivarsson et al. 
1979). By 1985, the fabrication techniques had been modi-
fied to produce small diameter vascular constructs (Wein-
berg and Bell 1986). The basic protocol to make standard 
collagen-based tubular construct is described in this 
Example. 
Collagen support structures were constructed from acid 
digested, Type I rat-tail collagen which had been dissolved 
12 
rate of this reaction is dependent upon both temperature and 
pH, and components used in the construct were kept on ice 
during fabrication to facilitate thorough mixing. Table 3.1 
describes the calculations used to determine the quantities of 
each component used in the collagen gels. Five times 
concentrated (5x) DMEM was added to buffer the solution 
while FBS was added to help the cells survive the fabrication 
procedure. Additionally, a slight excess of heat sterilized 
NaOH was used as recommended by the manufacturer to 
10 ensure proper gelation. 
TABLE 3.1 
Calculations for Fabrication of Basic Collagen Support Structures. 
15 Total Volume (ml) 
Number of Volume per (Note: 10% 
Constructs Made Construct (ml) excess was used) 
N 5.0 VTotal = 5.5 * N 
20 Component Volume Utilized Comments 
Type I Rat Collagen V Col = V Total * 2/Ccol Initial target 
(Isolated at Cc01 concentration 2.0 mg/ml 
mg/ml) in Acetic 
Acid (0.02 N) 
25 Autoclaved NaOH VNaOH = 0.22 *Veal Slight excess used to 
(0.1 N) ensure proper gelation 
FBS VFBS = 0.1 * VTotal Target concentration 
10% by volume 
5x DMEM VSxDMEM = 0.2 * VTotal 5x concentration reduced 
to -1 x during fabrication 
30 
Cell-DMEM Vcell = VTotal - Veal - Flexible volume accounts 
Suspension VNaOH - Yrns - for variability in Cc01 
YsxDMEM 
The assembly of cell-populated collagen support struc-
35 tures was initiated following the trypsinization of the cells 
which were to be incorporated into the graft. Populations of 
cells were estimated as previously described, and depending 
on the desired initial concentration of cells in each construct, 
an appropriate volume of suspended cells was centrifuged at 
40 1000 rpm (165 g) for 5 minutes to pellet the cells. Typically, 
lxl06 cells/ml initial seeding densities were targeted. The 
cell pellets were resuspended in lxDMEM and combined 
with a premixed solution of FBS, NaOH, and 5xDMEM. 
The mixtures were then combined with the dissolved col-
45 lagen in 50 ml centrifuge tubes and quickly transferred into 
glass test tubes. Glass mandrel assemblies consisting of 
glass capillary tubes outfitted with rubber end stoppers were 
then inserted into the glass test tube to form tubular geom-
etries. 
50 Once the collagen gel solutions were in the molds, the test 
tubes were sealed with ventilated caps and incubated at 37° 
C. for 30 minutes. After the tubular constructs had gelled, 
the caps of the assembly molds were removed and lumens of 
the capillary mandrels were threaded with a thin metal rod 
55 to break the suction which could potentially be created 
during removal of the constructs from the mold. The con-
structs were then gently pulled from the glass test tubes 
without damaging the gels. Using sterile forceps, constructs 
were placed in 150-mm suspension petri dishes filled with 
60 -140 ml ofprewarmed culture media. Tissue culture media 
were entirely replaced every 5-7 days. Typically, two con-
structs were grown in each petri dish. 
in 0.02 N acetic acid. The collagen was obtained from 
Collaborative Biomedical Products (Bedford, Mass.) and 
typically varied in concentration from 3.49 to 4.30 mg/ml 
depending on the lot. Neutralizing the collagen solutions 
with a weak base, such as 0.1 N NaOH, caused the acid- 65 
solubilized molecules to spontaneously aggregate to form 
polymeric chains in a process known as fibrillogenesis. The 
On occasion, the constructs were examined in a disk 
configuration. In these instances, the collagen gel solutions 
were poured into six-well tissue culture plates (2 ml per 
well) rather than the test tube/mandrel assemblies. The 
solutions were gelled at 37° C. for 30 minutes and covered 
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with 4 ml of culture media. Every twenty-four hours, the 
constructs were carefully released from the tissue culture 
plastic to permit free compaction. Tissue culture media were 
entirely replaced every two days. 
Example 3 
Exogenous Elastin Fragments 
Five types of elastins and elastin fragments were pur-
chased from Elastin Products Company, Inc. (EPC, Owens-
ville, Mo.) to investigate the effects of elastin fragments on 
vascular constructs. Two of the three insoluble elastins 
14 
on the preparation method utilized. Similarly, the two 
soluble elastins were designated as either Oxalic Acid or 
Peptide. 
The non-degradative method described by Starcher et al. 
used reagents that were specifically chosen to minimize the 
peptide cleavage observed in alkaline isolations (Starcher 
and Galione 1976). In addition to the autoclave and ethanol 
treatments used in the neutral isolation methods, trypsin, 
cyanogen bromide (CNBr) and ~-mercaptoethanol (~-ME) 
10 were employed to further digest the samples. Elastins are 
unaffected by trypsin and chymotrypsin protease digestion. 
Furthermore, their lack of methionine residues and low 
cysteine contents make reduction agents such as CNBr and 
studied were procured from bovine neck ligaments. One was 
purified using the neutral extraction method described by 15 
Partridge et al. (EPC, #E60) (Partridge, Davis et al. 1955). 
Briefly, minced bovine ligamentum nuchae were rinsed in a 
~-ME attractive isolation treatment candidates. 
Soluble elastins were prepared from the products of the 
neutral elastin extraction procedure described above. Bovine 
neck ligament elastins were solublized with a hot oxalic acid 
solution, clarified, dialyzed, and lyophilized. The products 
formed a salt-free water soluble particulate which coacer-
1 % (w/v) NaCl solution. The samples were treated with a 
series of autoclave cycles (1 ATM, 45 min/cycle) to remove 
collagen and mucopolysaccharides followed by ethanol or 
50% (v/v) ethanol-ether washes to remove the lipids. These 
processes were repeated, and ultimately, the samples were 
milled and filtered using a fine-mesh sieve. The resulting 
insoluble elastins exhibited alterations in their dye-staining 
character and adsorptive capacity for proteolytic enzymes 
compared to alkaline-digested specimens (Partridge, Davis 
et al. 1955). Gotte et al. also found that elastins which had 
been purified using this neutral isolation process possessed 
more free a-amino groups than those purified in alkaline 
conditions for extended periods of time. This was attributed 
to decreased hydrolytic damage to the peptide bonds. Little 
to no change in the number of interchain covalent crosslink-
ages was observed with the neutral extraction process 
(Gotte, Stern et al. 1963). 
Alkaline isolations were performed according to the 
extraction methods described by Lowry et al. (Lowry, Gil-
ligan et al. 1941). In short, tissue was minced and placed in 
a solution of 0.1 N NaOH overnight. The NaOH solution 
was replaced and the tissue was incubated for an additional 
two hours. The pH was neutralized, and the tissue was 
incubated in a alcohol/ether solution (3: 1 v:v). The tissue 
was autoclaved at 50 psi for four hours, ground, and incu-
bated in a boiling 0.1 N NaOH bath for twenty minutes. The 
first half of the procedure was designed to isolate both 
collagen and elastin proteins while the boiling NaOH solu-
tion was the key step in the elastin extraction. Analysis of 
hydroxyproline and amino acids were used to monitor the 
purity both during and after preparation. The final product 
was free of fat, muscle, collagen, and connective tissue and 
was reported to contain less than 0.01 % insoluble residue 
following elastolysis. 
A third method used a non-degradative process described 
by Starcher et al (Starcher and Galione 1976) to purify 
insoluble bovine aortic elastin (EPC, #SB87). A portion of 
the neutrally extracted elastin was further processed with hot 
oxalic acid and dialyzed to form a soluble, salt-free material 
capable of forming a coacervate at pH 5.0 and 37° C. (EPC, 
#ES12). Some of the alkaline extracted elastin was hydro-
lyzed with porcine pancreatic elastase, boiled and filtered to 
form a highly soluble fifth material (EPC, #CB573). This 
product which contained desmosines, isodesmosines, and 
Val-Gly-Val-Ala-Pro-Gly repeating peptides, exhibited a 
molecular weight range from 1,000 to 60,000 with ca. 60% 
passing a 3000 MWCO hollow fiber at 6 psi (manufacturer's 
data). The three insoluble elastins, which were obtained in 
37-149 µm particles, were designated as Neutral Extraction, 
Alkaline Extraction, or Non-Degradative Elastin depending 
20 vated at pH 5.0 and 37° C. Exogenous, soluble elastin 
peptides were prepared from the products of the alkaline-
mediated isolation process described above. Isolated 
insoluble elastins were hydrolyzed completely using porcine 
pancreatic elastase, filtered, and lyophilized. The resulting 
25 material, which varied in molecular weight from 1,000-60, 
000 Da, contained both the Val-Gly-Val-Ala-Pro-Gly repeat 
peptide and the desmosine and isodesmosine crosslink moi-
eties. 
The fabrication methods described in Example 2 for 
30 collagen constructs were modified slightly to create cell-
seeded constructs containing exogenous elastin fragments. 
Each exogenous elastin was massed in a sterile weigh boat 
and combined with the acid-soluble rat tail collagen in a 50 
ml centrifuge tube to form either a 1: 1 or 1 :5 collagen-elastin 
35 mixture (i.e. CEZast equal to lxCc
0
z or 5xCc01). Conse-
quently, as the collagen concentrations were diluted to 2 
mg/ml, the concentrations of elastin fragments were like-
wise diluted to final concentrations of either 2 or 10 mg/ml. 
The mixtures were vortexed and placed on a shaker plate at 
40 4 ° C. for at least 18 hrs prior to being used to make 
constructs. The soluble elastins dissolved readily into the 0.2 
N acetic acid. The insoluble elastins formed a cloudy 
precipitate which tended to settle out of solution. These 
particles were resuspended through vortexing and/or pipet-
45 ting just before the collagen-elastin mixtures were added to 
the constructs. Other than the formation of the collagen-
elastin solution, the vascular constructs were prepared as 
previously described. 
Three insoluble and two soluble forms of elastin were 
50 investigated. As described above, the insoluble elastins were 
purified by either neutral extraction, alkaline extraction, or 
through non-degradative processes and will be referred to as 
"Neutral", "Alkaline", or "Non-Degradative/Aortic", 
respectively. Hot oxalic acid processing was utilized to form 
55 a soluble material which will be referred to as "Oxalic/ 
Oxalic Acid". Elastase was also used to form a soluble 
Val-Gly-Val-Ala-Pro-Gly penta-peptide repeat sequence. 
This second soluble material will be referred to as "Peptide". 
Fragments of elastin were added to collagen to form either 
60 2 mg/ml (Low) or 10 mg/ml (High) concentrations. Due to 
the cost of the material, experiments involving Non-Degra-
dative and Oxalic elastin fragments were only performed at 
low concentrations. Collagen-based constructs fabricated 
without exogenous fragments of elastin will be referred to as 
65 "Control" or "Collagen Controls". The concentration of 
collagen was kept constant (2 mg/ml) throughout all sample 
types. 
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Gel Compaction Data 
Following their incorporation into collagen-based gels, 
the HDFs quickly remodeled their surrounding matrices. 
Macroscopically, constructs containing low and high con-
centrations of soluble elastin looked similar to collagen 
controls. Constructs fabricated with insoluble elastins, how-
ever, acquired a coarse appearance after the eight day 
culturing period as the particles of elastin could be seen 
throughout the translucent collagen gel. This effect increased 
with elastin concentration as the high insoluble constructs 
took on a yellowish, granular appearance. 
Quantitatively, incorporation of elastin fragments into the 
constructs affected the degree of matrix compaction attained 
16 
cellular components blue and the extracellular matrix pink. 
From these micrographs, it was seen that while cells are 
dispersed throughout the entire thickness of the constructs, 
a large concentration of cells has migrated to or proliferated 
on the outer wall. In both collagen controls and samples 
containing soluble elastins, the walls of the constructs were 
comprised of diffuse networks of fibers which had been 
colored faint pink. The samples containing insoluble elastins 
also exhibited the dense outer layer of cells surrounding a 
10 weakly stained network of fibers, but in addition to this, the 
elastin fragments presented as dark, geometric particles 
throughout the walls of the constructs. As the initial con-
centrations of insoluble elastin were increased from 2 to 10 
mg/ml, the concentration of particles increased proportion-
15 ally. 
by the cells. After eight days of culture, insoluble elastins 
elicited a reduced degree of compaction (Insoluble-High vs. 
Control, p<0.0001; Insoluble-Low vs. Controlp<0.49) while 
soluble elastins had little to no observable impact on con-
struct compaction (Soluble-High vs. Control, p<0.988; 
Soluble-Low vs. Control, p<0.30). Constructs containing 
neutrally isolated insoluble elastin at low and high concen- 20 
trations occupied 144.6% (p<0.677) and 211 % (p<0.015) of 
the volume occupied by control constructs, respectively. 
Neutral-High constructs took up 146.3% (p<0.64) of the 
space that Neutral-Low constructs occupied. On average, 
constructs containing alkaline insoluble elastin at low and 25 
high concentrations occupied 124.7% (p<0.995) and 184.2% 
(p<0.126) of the volume occupied by control constructs, 
respectively. Likewise, Alkaline-High constructs took up 
147.8% (p<0.74) of the space occupied by Alkaline-Low 
constructs. At low concentrations, insoluble elastins isolated 30 
using non-degradative processes did not elicit a statistically 
significant change in construct gel compaction. Soluble 
elastin digested with oxalic acid also did not have a statis-
tically significant impact on the degree of compaction. 
While constructs containing soluble elastin peptides at low 35 
concentrations occupied 168.5% (p<0.35) of the volume as 
control constructs, this percentage dropped to 110.3% 
(p<0.999) at the higher concentrations. 
Immunostaining of sectioned tissues using a murine BA-4 
monoclonal primary and a FITC-conjugated secondary was 
utilized to identify elastin components in the matrix. In 
constructs containing insoluble elastin fragments, non-uni-
form particles were evenly distributed throughout the wall of 
the construct and presented as a striking green. No staining 
was visible in either the samples containing soluble elastins 
or the collagen controls. Verhoff's stain, a histological 
marker that preferentially dyes elastin and elastic fibers, 
resulted in similar findings as in the immunofluorescent 
assays. Cellular components and the "crystalline-shaped" 
particles in the constructs containing insoluble elastin pre-
sented dark black while none of the soluble elastin in either 
the Oxalic or Peptide constructs was seen. These findings 
may indicate that the soluble elastins diffused out of the 
constructs during the course of the experiments or they may 
simply result from the fact that the processing steps involved 
in isolating the soluble elastins removed the antigen binding 
sites from the materials. 
Cellular viability in constructs containing elastin frag-
ments was assessed through live-dead staining. All con-
structs had a high ratio of viable (green) to nonviable (red) 
cells. In control constructs and constructs containing soluble The thicknesses of the construct walls followed similar 
trends as the overall gel compaction data. All five exogenous 
elastin fragments resulted in increased observed mean wall 
thicknesses compared to control constructs. These effects 
reached statistical significance in the Neutral-High (100% 
increase, p<0.0020) and Alkaline-High (79% increase, 
p<0.014) samples. The wall thicknesses in the other elastin 
samples did not differ statistically from control samples. On 
average constructs containing insoluble elastins were sig-
nificantly thicker than controls (Insoluble-High vs. Control, 
p<0.0001; Insoluble-Low vs. Control, p<0.166). Constructs 
containing soluble elastins were statistically equivalent to 
controls (Soluble-High vs. Control, p<0.993; Soluble-Low 
vs. Control, p<0.999). 
Histology and Viability Staining 
While gel compaction analysis provides some informa-
tion regarding overall cellular function, it only relates to 
macroscopic behaviors. In order to identify subtle similari-
ties and differences between constructs with and without 
exogenous elastins, microscopic staining strategies were 
combined with some relatively simple molecular biological 
assays. Histological and immunofluorescent staining of sec-
tioned tissues was used to characterize cell and matrix 
organization throughout the constructs while live-dead 
analysis and total DNA assays were attempted to character-
ize cell viability and proliferation. 
Histological examination of the constructs using Haema-
toxylin and Eosin Y staining (H&E) colored nuclei and other 
40 elastins, the cells were distributed throughout the entire 
matrix. In constructs containing insoluble elastin fragments, 
irregularly-shaped regions were seen which did not contain 
any cells. The sizes and shapes of these voids were consis-
tent with the particles visualized in the histological staining, 
45 and consequently they were supposed to be regions of 
insoluble elastin fragments which prevented cellular 
ingrowth. The outer edge of each construct contained a layer 
of viable cells as seen in the H&E stains. 
In addition to its role in maintaining the mechanical 
50 integrity of blood vessels, elastin has also been shown to 
have biochemical effects on cell behavior. Ito et al. have 
shown that cells seeded in collagen gels containing soluble 
a-elastin components exhibit decreased migratory and pro-
liferative capabilites (Ito, Ishimaru et al. 1997; Ito, Ishimaru 
55 et al. 1998). While no overt differences in overall cell 
populations were detected in the sectioned histological 
stains, a Hoescht total DNA assay was attempted to identify 
the number of cells in each type of construct. Control 
samples which did not contain exogenous elastins demon-
60 strated an average increase in cell count over an eight day 
culturing period. When this assay was extended to constructs 
containing soluble and insoluble elastin fragments, the elas-
tin materials elicited positive signal readings. Furthermore, 
since it was not possible to determine how much elastin 
65 diffused out of the constructs with culturing, the Hoescht 
DNA assay was not able to ascertain the number of cells 
present in each construct. 
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The findings described in this section demonstrate some 
of the potential biochemical effects that elastic fibers can 
have on vascular constructs. Although issues such as cell 
viability, cellular migration and proliferation, and ECM 
organization are important considerations to address when 
developing a tissue engineered blood vessel replacement, 
they were only a small part of the overall goals of these 
studies. While additional experiments and assays could be 
have been attempted to elucidate these effects, the bulk of 
the research efforts in these studies focused on exploring the 
interactions between elastin and the mechanical properties 
of the constructs. 
Uniaxial Tensile Testing 
Uniaxial tensile testing was conducted on -5 mm ring 
samples to assess the overall strengths of constructs con-
taining fragments of exogenous elastin. Both collagen con-
trol samples and samples containing elastin fragments 
exhibited similar general stress-strain profiles. They pos-
sessed a characteristic "toe-region", followed by a quasi-
linear regime which eventually plateaued into a region of 
yielding and deformation before ultimate failure. 
Ultimate Stresses and Linear Moduli 
10 
18 
In general, soluble and insoluble elastins did not have a 
statistically significant impact on either the yield or failure 
energies. Of all the treatment levels investigated, only the 
Peptide-Low (p<0.81) and Peptide-High (p<0.13) exhibited 
p-values less than 0.9 when the yield energies were com-
pared with the collagen control samples. Similarly, only the 
Peptide-High (p<0.76) exhibited a p-value less than 0.9 
when the failure energies were compared with the collagen 
control samples. 
It was found that incorporating either soluble (Soluble-
Low, p<0.056; Soluble-High, p<0.93) or insoluble (In-
soluble-Low, p<0.64; Insoluble-High, p<0.22) exogenous 
elastins into the collagen constructs caused the observed 
15 mean ratio to increase. A larger ratio indicated a larger 
degree of plasticity. While none of the parameters reached 
statistical significance, the values tended to increase indi-
cating that exogenous elastin fragments may cause the 
constructs or soft tissue devices to endure more plastic 
20 deformation prior to failure. As used herein throughout the 
specification, the terms construct and device are inter-
changeable. 
Example 4 
Intact Elastin Scaffold 
Intact elastin scaffolds were procured from the arteries of 
adult pigs (3-5 mm ID). After the pigs were shocked, 
exsanguinated, and skinned, an incision was made from the 
top of the sternum to the chin using a scalpel. The tissue was 
separated with retractors and the left and right carotid 
arteries were removed using surgical scissors and forceps. 
In general, insoluble elastins resulted in decreased ulti- 25 
mate tensile stresses (Insoluble-Low vs. Control, p<0.72; 
Insoluble-High, p<0.009) while soluble elastins did not 
(Soluble-Low vs. Control, p<0.75; Soluble-High, p<0.201). 
Constructs containing neutrally isolated insoluble elastin at 
high concentrations exhibited a 45.0% (p<0.09) decrease in 30 
the observed mean UTS compared to controls. Similarly, 
constructs containing alkaline-digested elastins at high con-
centrations exhibited a 48.2% (p<0.07) decrease in the UTS 
parameter. No other individual treatment levels approached 
statistical significance. 35 
Excess blood was washed off each vessel with a phosphate 
buffered saline (PBS) solution (pH 7.4) containing antibi-
otic-antimycotic (Gibco BRL, Gaithersburg, Md.). Saline 
was also infused through the lumen to remove any blood 
clots. Once cleaned, the arteries were immersed in fresh 
Unlike the UTS trends, the observed mean linear moduli 
tended to increase in the presence of insoluble elastins 
(Insoluble-Low vs. Control, p<0.395; Insoluble-High vs. 
Control, p<0.62) while giving mixed results in the presence 
of soluble elastins (Soluble-Low vs. Control, p<0.62; 40 
Soluble-High vs. Control, p<0.999). While the overall trends 
in the linear modulus may have directed upward, no statis-
tically significant differences were observed in with any of 
the individual treatment levels or elastin groups. 
It is likely that many of the observed trends would reach 45 
significance if the sizes of the sample sets were increased. 
Since the uniaxial tensile testing measurements were based 
on the original, unstressed dimensions of the samples, some 
decreases in peak stresses would be expected and could be 
attributed to the differences in the thicknesses of the sample 50 
walls. These explanations, however, would not account for 
all of the observations, such as the mixed trends observed 
with some of the soluble elastins. Still, it is important not to 
read too much into the data as most of the differences were 
saline and stored on ice. 
As sUlllillarized in Table 3.2, the elastin scaffolds were 
isolated from the porcine carotids using a series of enzy-
matic, chemical, and thermal treatments. Briefly, arteries 
were incubated in a pH neutral sodium phosphate buffer 
solution for three twenty-four hour cycles to thoroughly 
clean each vessel. Excess adventitia was then removed using 
surgical scissors and forceps, and the arteries were cut into 
1.25" long segments and loaded onto the capillary tube 
mandrel assemblies. Arterial segments were then immersed 
in 100 ml of deionized (DI) water and autoclaved for sixty 
minutes at 17.4 PSI. Upon completion of each cycle, the 
water was removed while still hot and replaced. The arteries 
were then reautoclaved for a subsequent sixty minutes. A 
total of five autoclave cycles were conducted. Arterial seg-
not statistically significant. 55 ments were then placed in a 0.0133% trypsin-tris buffer 
solutions and incubated at 37° C. for 18 hrs. 
Yield and Failure Energies 
In order to obtain some further information regarding the 
effects of exogenous elastins on the overall strengths of the 
constructs, the areas under the uniaxial tensile test stress-
strain curves were utilized to evaluate construct toughness. 
By normalizing the data by the length of sample tested, it 
was possible to estimate the amount of energy needed to be 
applied to each construct to bring it to the point of yielding 
and to the point of failure. The ratios of these yield and 
failure energies were used to identify the mode by which the 
samples failed. 
Following the enzymatic digestion, the segments were 
incubated in a cyanogen bromide (CNBr)-formic acid reduc-
ing solution for six hours. Further digestion was performed 
60 overnight in a ~-mercaptoethanol, urea solution. A twenty-
four hour ethanol incubation was used to help remove 
contaminant lipids and to sterilize the scaffold segments. 
Upon the introduction of ethanol, the scaffolds were handled 
asceptically. Finally, three twenty-four hour washings were 
65 performed in sterile PBS at 4 ° C. to remove residual ethanol. 
At this point, the isolated elastin scaffolds were ready to be 
incorporated into TE vascular grafts. 
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TABLE 3.2 
Isolation Procedure for Intact Elastin Scaffolds. 
Procedure Duration Comments 
Sodium phosphate 3 x 24 hrs @ 4° C. Slight agitation 
buffer washes 
(0.05 M, pH 7.6) 
Autoclave treatments 5 x 60 min @ 17.4 PSI DI water was 
(100 ml DI replaced while hot 
water/segment) (immediately after 
completion of cycle) 
Trypsin-Iris buffer 18 hrs@ 37° C. 0.0133% trypsin 
digestion (0.1 M, pH (w:v) 
8.2) Containing 0.02 
M CaC12 
DI water rinses 3 x 5 min 2% cyanogen 
Cyanogen bromide- 6 hrs @ room temperature bromide (w:v) 
formic acid digestion Slight agitation 
DI water rinses 3 x 20 min 0.5% 13-
13-mercaptoethano 1- 18 hrs @ room temperature mercaptoethanol 
tris buffer digestion (v:v) 
(0.05 M, pH 8.0) Slight agitation 
Containing 6 M urea 
DI water rinses 3 x 20 min 
Ethanol incubation 24 hrs@ 4° C. -40 ml/segment 
Sterile conditions 
maintained from this 
point onward 
PBS washes 3 x 24 hrs -40 ml/segment 






described by Starcher et al. (Starcher and Galione 1976) 
were selected based on their ability to digest collagens, 
lipids, and proteoglycans without damaging the elastic 
matrix. 
Rates of protein removal were assessed through a Bicin-
choninic Acid (BCA) colorimetric assay (Pierce, Rockford, 
Ill.) on the processing/digestion solutions. Bovine serum 
albumin (BSA) was used as a standard. Substantial quanti-
ties of protein were removed in the first few sodium phos-
phate rinses as serum proteins and other clotted blood 
components were washed away. Similarly a substantial 
quantity of protein was removed in the initial autoclave 
cycle. Diminishing amounts of protein removal were 
observed in subsequent sodium phosphate rinses and auto-
clave incubations as the effects of the treatments decayed. 
While a third spike in protein removal was observed during 
the trypsin digestion, samples from the cyanogen bromide 
and ~-mercaptoethanol digestions were not analyzed. 
Weight loss during arterial processing was assessed to 
help determine the amount of ECM and cellular debris lost 
during each treatment step. After blotting scaffolds on piles 
of absorbant wipes (30 seconds each side) to remove excess 
fluid, each sample was weighed on balance and normalized 
to their original weight prior to the first autoclave cycle. 
Sample weight initially increased to 136% of the original 
values as the constructs swelled during the initial autoclave 
treatments. This was followed by a sharp decrease in weight 
As with the exogenous elastin fragments, the fabrication 
process described in Example 2 was modified to incorporate 
isolated elastin scaffolds into the collagen gels. Cell-seeded 
collagen gels were prepared and transferred into the tubular 
molds as previously described. The mandrels and isolated 
scaffolds were then inserted into the molds and elevated up 
and down to allow the collagen gel to infiltrate regions on 
both sides of the elastin scaffold. While the majority of the 
collagen gel resided on the outside of the elastin scaffold, 
small gaps between the elastin and mandrel permitted some 
collagen to infiltrate the inner lumen of the scaffold. Addi-
tional steps were performed as previously described. 
30 as the constructs dropped to 27% of their original mass in 
subsequent autoclave cycles. Although it was not measured 
at each step, weight loss continued with additional treat-
ments until the constructs eventually dipped below 15% of 
their original mass. As described earlier in Table 2.1, elastin 
35 comprises between 15 and 25% of the dry, defatted tissue in 
small diameter arteries. The water and fat in these tissues 
typically range from 65 to 75% of the total weight (Dobrin 
1997). Since the isolated elastin matrices were not dehy-
drated prior to each weight measurement, it is difficult to 
40 make direct comparisons between the various treatments. 
Constructs fabricated with isolated elastin scaffolds were 
studied to examine the effects of known amounts of highly 
structurally organized elastic fibers on the properties and 
function of vascular grafts. Experiments investigating gel 
compaction, histological staining, and mechanical testing 45 
were conducted. The results described correspond to experi-
ments performed on tubular constructs seeded with either 
HDFs or RASMs and cultured statically on 3-mm glass 
mandrels for either eight or twenty-three days. Constructs 
containing an isolated arterial elastin scaffold are generally 50 
referred to as "Elastin Hybrids" while those constructed 
without the elastin component are referred to as "Collagen 
Controls". While complete studies on both the rat and 
human cells were performed, the experiments were designed 
to explore effects between treatment levels and culturing 55 
periods rather than between cell types. Consequently, the 
HDF and RASM data in the subsequent sections are pre-
sented separately. Occasionally, when the results observed 
for the respective cell types were markedly different, cross-
comparisons were noted to indicate behaviors in which the 60 
cell types may be functioning differently. 
Elastin Scaffold Isolation Studies 
Nevertheless, the values are similar enough so as to be 
roughly compatible with one another. 
Macroscopically these isolated elastin scaffolds differed 
significantly from their undigested counterparts. When arte-
rial sections were stained using BA-4 monoclonal anti-
elastin antibodies, the elastic structures throughout the arte-
rial wall could be visualized. A wavy internal elastic lamina 
surrounded by concentric lamellar ring structures were seen 
throughout the intima and media components of the artery. 
These structures were surrounded by a mesh of elastic fibers 
which extended into the adventitia. All of these structures 
remained intact following the elastin digestion procedure. 
Furthermore, the components presented more intensely as 
more antigen sites on the elastic fibers were presumably 
exposed to bind the antibody. This indicates that the diges-
tion procedure was successful in isolating an intact elastin 
matrix. Attempts to stain for collagen remnants in the 
isolated matrix were unsuccessful. 
The mechanical properties of the isolated elastin scaffolds 
as assessed through uniaxial tensile testing are summarized 
in Table 4.2. Although only preliminary testing was per-
formed (One Batch, n=2), these data demonstrate that a 
considerable loss of strength occured during the digestion It is desired that purification methods capable of removing 
ECM proteins and cellular debris from native arteries while 
leaving the elastin fiber network relatively intact. 
Approaches modified slightly from those originally 
65 process. Furthermore, variations in the isolation process had 
little impact upon the resulting mechanical properties of the 
scaffolds. 
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It was observed that the uniaxial tensile parameters of the 
isolated elastin scaffolds are approximately an order of 
magnitude larger than those of unreinforced, collagen-based 
constructs. 
TABLE 4.2 
Uniaxial Tensile Mechanical Parameters of Isolated Elastin 
Scaffolds. Scaffolds were isolated from porcine carotid 
arteries. Ultimate tensile stresses and linear moduli are 
reported ± standard error. Data corresponds to n = 2. 
Uniaxial Tensile Linear 
Isolation Process Stress (kPa) Modulus (kPa) 
Undigested Native Artery 1,980 ± 280 3,430 ± 58.8 
Full Digestion 69.8 ± 20.6 106 ± 32.2 
No 13-ME or CNBr 55.2 ± 17.6 146 ± 5.5 
One Autoclave Cycle 69.4 ± 9.2 114 ± 9.1 
Gel Compaction Data 
22 
original volume (p<0.35 vs. RASM Hybrid-Day 8, p<0.46 
vs. RASM Control-Day 23, p<0.34 vs. HDF Hybrid-Day 23) 
Shown in FIG. 4, the changes in the thickness of the 
RASM construct walls followed the time-dependent com-
paction trends during the twenty-three days of culturing. 
From day eight to day twenty-three, the elastin hybrid 
constructs exhibited a 14% reduction in wall thickness 
(p<0.57). Likewise, the collagen control constructs exhib-
ited a 19% reduction in wall thickness over the same time 
10 span (p<0.31). The effects of the elastin scaffold on wall 
thickness seen in the HDF experiments were not observed in 
the RASM constructs. A 6% decrease (p<0.93) was actually 
observed at day eight while only 1 % increase (p<0.9999) 
was observed in mean thickness values between elastin 
hybrid and collagen control constructs at day twenty-three. 
Some of the differences observed between cell types can be 
attributed to the fact that RASMs do not remodel and 
15 
compact their surrounding matrix as vigorously as HDFs. 
With the decreased overall compaction in RASM constructs, 
20 it is likely that the defined volume of the refractory elastin 
scaffold did not impact the overall construct dimensions as 
much as it did in the HDF constructs. 
Following the incorporation of a collagen gel cell com-
position about the elastin scaffold, the cells rapidly com-
pacted their surrounding matrix. Illustrated in FIGS. 1 and 2, 
both the HDFs and RASMs exhibited similar compaction 
trends with and without the isolated elastin scaffold com- 25 
Histological Staining 
Histological examination of the elastin hybrid constructs 
ponents. Differences between the elastin-hybrid constructs 
and the collagen-based controls mainly resulted from the 
elastin scaffold which was fairly resistant to cell-based 
reorganization and presented a physical barrier to compac-
tion. While compaction rates were highest in the initial days 
following construct fabrication, collagen matrix remodeling 
and volume reduction continued to occur throughout the 
twenty-three days investigated. 
HDFs were capable of high degrees of collagen gel 
compaction. After eight days of culture, the collagen-based 
gels contained only 6.2% of their original volumes. This 
behavior continued until only 3.3% of the original volume 
remained after twenty-three days of development (p<0.07 
was performed using H&E staining. The elastin matrix 
presented darker than the fibers of the reconstituted collagen 
gel. The ECM of native arteries was colored much darker 
than either the elastin hybrid or collagen control samples 
30 when stained for equal time durations. As seen previously in 
the exogenous elastin fragment studies, the elastin hybrid 
and collagen control samples exhibited dense layers of cells 
along the outer walls of the constructs. Overall, however, the 
cell density in native arteries was higher than in the TE 
35 grafts. 
The majority of collagen and cells in the elastin hybrids 
was located along the outer edge of the constructs. A thin 
layer of cell-seeded collagen could be seen along the inner 
lumen where the gel had formed between the elastin scaffold 
40 and glass mandrel. Although a few cells could be visualized 
inside the elastin structure, the vast majority of cells 
remained in the collagen components of the constructs. 
vs. Day 8). When scaffolds of isolated elastin were incor-
porated into the gels, compaction to 13 .1 % of the original 
construct volume was observed after eight days of culture 
(p<0.0001 vs. Collagen Control). After twenty-three days of 
culture, only 9.9% of the original elastin-hybrid construct 
volume remained (p<0.16 vs. Elastin Hybrid-Day 8; 
45 
p<0.0003 vs. Collagen Control-Day 23). 
Uniaxial Tensile Testing 
Uniaxial tensile testing was conducted on -5 mm ring 
samples to assess overall strengths of the constructs with and 
without an elastin scaffold supplement. The general profiles 
of the elastin hybrid and collagen control stress-strain rela-
tionships had some notable similarities and differences. Both 
Shown in FIG. 3, changes in the wall thicknesses of the 
HDF constructs mirrored the overall compaction trends. 
Following an eight day culturing period, the walls of elastin 
hybrid constructs seeded with HDFs were 1.5-fold thicker 
on average than in the collagen-based controls (p<0.03). By 
day twenty-three, this effect had increased to a 2.7-fold 
differential (p<0.006) as the collagen continued to compact 
while the dimensions of the elastin scaffold remained rela-
tively unchanged. 
Experiments using rat cells revealed slightly reduced 
RASM gel compaction capabilities compared to HDFs. 
After eight days of culture, collagen-based control con-
structs seeded with RAS Ms occupied 17 .9% of their original 
volume (p<0.001 vs. HDF). Compaction in RASM con-
structs continued beyond the eight day observation point, 
and only 12.7% of the original construct volume remained 
after twenty-three days of culture (p<0.27 vs. Day 8; 
p<0.001 vs. HDF-Day 23). At day eight, hybrid scaffold 
constructs occupied 21.1 % of their original volume (p<0.72 
vs. HDF Hybrid, p<0.59 vs. RASM Control). At day twenty-
three, hybrid scaffold constructs occupied 16.8% of their 
50 types of constructs exhibited characteristic "toe-regions" at 
the onset of the stress-strain profiles as ECM components 
such as collagen and elastic fibers were recruited and 
oriented by the hooks of the mechanical testing apparatus. 
The two types of constructs differed most notably in terms 
55 of the peak stresses attained prior to failure, but besides 
these differences in stress magnitudes, elastin scaffold con-
structs tended to exhibit more truly linear"linear modulus" 
regions which extended up to the point of peak stress. 
Following this point, some of the elastin scaffold constructs 
60 failed abruptly while others tore partially and exhibited 
secondary and tertiary linear stress-strain "saw tooth" 
regions before ultimately failing. The linear stress-strain 
region of the control constructs had a more gradual termi-
nation as the graded onset of plastic deformation resulted in 
65 steady decreases of the stress-strain modulus. This plastic 
deformation frequently spanned a 50% region of strain. As 
collagen fibril bundles tore and slid past one another, the 
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stresses continued to increase initially but eventually 
decayed and dropped down to nominal levels. 
Ultimate Stresses and Linear Moduli 
24 
isolation and construct fabrication procedures, was most 
likely the cause for the large standard deviations observed. 
The ultimate stress and linear modulus mechanical param- 5 
eters of constructs seeded with HDFs are summarized in 
FIGS. 5 and 6. Elastin hybrid constructs cultured statically 
for eight days exhibited 14.1-fold higher mean ultimate 
stresses (p<0.0001) than unreinforced control constructs. 
After twenty-three days of culture, the UTS increase had 10 
dropped to 7.2-fold (p<0.0001). This was due primarily to 
the larger observed mean UTS exhibited by the collagen 
control constructs which rose 65% from 3 .2 kPa at day eight 
At first glance, it would appear that the UTS increase in 
the collagen control samples would signify that the overall 
mechanical strengths of the constructs were increasing. 
While this is likely to be the case, it is important to note that 
some of the observed increases in stress values were the 
result of reductions in cross-sectional area caused by 
changes in the thicknesses of the sample walls. Eventually 
it would be desirable for the rate of cellular matrix synthesis 
to balance with the rate of matrix compaction and reorga-
nization such that increases in ultimate stresses occur inde-
pendent of the construct dimensions. 
to 5.3 kPa at day twenty-three (p<0.45). Elastin hybrid 
constructs, on the other hand, exhibited no change in UTS 15 Yield and Failure Energies 
(p<0.9995) between the two time points investigated. 
The linear moduli of the HDF constructs was also higher 
in the presence of elastin scaffolds. At day eight, the average 
linear modulus for the elastin hybrids was 4.6-fold higher 
than for the collagen controls (p<0.0001). At day twenty-
three, the modulus was 3.4-fold higher (p<0.0002). Again, 
the observed decrease in influence was due primarily to 
modulus changes in the collagen control samples which rose 
31% from 13.7 kPa to 18.0 kPa (p<0.75) while the same 
parameter in the elastin hybrid samples remained constant 
(p<0.9999) during the additional 15 days of culturing. 
The ultimate stress and linear modulus mechanical param-
eters of constructs seeded with RASMs are summarized in 
FIGS. 7 and 8. Elastin hybrid samples cultured statically for 
eight days exhibited a 7.2-fold larger mean UTS compared 
to collagen controls (p<0.002). Unlike HDF-seeded con-
structs, similar effects were observed after twenty-three days 
As described previously, the areas under the stress-strain 
curves can be utilized to give an idea of the degree of 
toughness in different construct samples. In the constructs 
20 
populated with HDFs, summaries of the yield and failures 
energies can be seen in FIGS. 9 and 10. At day eight, 
constructs with an elastin scaffold possessed 41.0-fold 
(p<0.0001) and 17.1-fold (p<0.0001) larger yield and failure 
energies, respectively. These effects were mirrored at day 
25 
twenty-three with 33.9-fold (p<0.0001) and 28.7-fold 
(p<0.000 1) larger yield and failure energies with the incor-
poration of an elastin scaffold. In general, the energy param-
eters of the elastin hybrid and collagen control constructs did 
not change significantly with time in culture. The yield 
30 
energies of the elastin hybrid constructs dropped 31 % from 
0.223 ml/mm to 0.154 ml/mm (p<0.93) while in the col-
lagen controls, the mean yield energies dropped from 0.0054 
ml/mm to 0.0045 ml/mm (p<0.59). The observed mean 
failure energy of the elastin hybrid constructs dropped 13% of culture as elastin hybrid UTS values were 8.0-fold higher 
than their collagen control counterparts (p<0.0007). As with 
the HDFs, observed mean ultimate stress values of RASM 
control samples rose 41 % between days eight and twenty-
three (p<0.71). Unlike the HDF samples, however, RASM 
elastin hybrid constructs exhibited a similar 57% larger UTS 
between at day twenty-three than at day eight (p<0.32) and 
40 
consequently maintained the observed difference between 
hybrids and controls 
35 
from 0.276 ml/mm to 0.241 ml/mm (p<0.99) while the 
failure energies of the collagen controls dropped 48% from 
0.0161 ml/mm to 0.0084 ml/mm (p<0.12). 
The ratios of yield energy to failure energy for constructs 
seeded with HDFs are shown in FIG. 11. These ratios were 
higher in control constructs at day eight (2.1-fold higher, 
p<0.01) but not day twenty-three (1.2-fold higher, p<0.89). 
This indicated that at day eight, the control constructs 
exhibited a substantial degree of plastic deformation prior to 
failure while the elastin hybrid constructs were prone to 
In general, the observed mean wall stiffnesses of the 
RASM constructs tended to be higher in the presence of the 
elastin scaffolds but did not result in statistically significant 
changes. At day eight, the linear modulus of the elastin 
hybrid constructs was, on average, 1.4-fold higher than in 
the collagen control constructs (p<0.82). At day twenty-
three, the change had increased to a 2.2-fold difference for 
the two sample conditions (p<0.093). Control constructs 
seeded with RASMs exhibited no change in stiffness with 
culturing and possessed linear moduli of 28.1 kPa and 26.4 
kPa at days eight and twenty-three respectively (p<0.992). 
Elastin hybrid constructs, on the other hand, exhibited a 
1.5-fold increase in stiffness during the culturing period as 
their mean linear moduli rose from 39.4 kPa to 59.3 kPa 
(p<0.47). 
In addition to affecting ultimate stress and construct 
stiffness parameters, the incorporation of an elastin scaffold 
also manifested in a larger degree of variance between 
samples. Much of this increased scatter could be attributed 
to sample to sample variability that took place between the 
isolated elastin scaffolds. Since the scaffolds were obtained 
from porcine carotid arteries, differences in size, diet, and 
genetic background of the pigs could result in changes in 
size, organization, and composition of their carotid arteries. 
This, coupled with variability introduced during the scaffold 
45 more sudden, "brittle" modes of failure. With culturing, the 
observed mean energy ratios of the collagen control samples 
dropped 35% (p<0.08) indicating that their failure mecha-
nisms may have been changing to a more abrupt nature. The 
energy ratios of the elastin hybrid samples remained 
50 unchanged (p<0.99) indicating little to no change in the 
failure mechanisms. 
In the constructs populated with RASMs, summaries of 
the yield and failures energies can be seen in FIGS. 12 and 
13. At day eight, constructs with an elastin scaffold demon-
55 strated 22.2-fold (p<0.002) and 3.6-fold (p<0.004) larger 
yield and failure energies, respectively. These trends were 
mirrored at day twenty-three with 12.2-fold (p<0.03) and 
3.2-fold (p<0.03) larger yield and failure energies with the 
incorporation of an elastin scaffold. The energy parameters 
60 of constructs seeded with RASMs did not necessarily 
decrease with culturing. While the mean yield energy of the 
elastin hybrid constructs dropped slightly from 0.205 
ml/mm to 0.183 ml/mm (p<0.26), the yield energy values in 
the collagen controls rose 62% from 0.0092 ml/mm to 
65 0.0150 ml/mm (p<0.05). The mean observed failure energy 
of the elastin hybrid constructs remained constant at 0.232 
ml/mm and 0.247 ml/mm (p<0.91) while the failure ener-
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gies of the collagen control samples rose 19% from 0.0635 
ml/mm to 0.0756 ml/mm (p<0.40). 
The ratios of yield energy to failure energy for constructs 
seeded with RASMs are shown in FIG. 14. These ratios were 
higher in control constructs both at day eight (5.4 fold 5 
higher, p<0.0001) and day twenty-three (3.3-fold higher, 
p<0.004) indicating that the control constructs exhibited a 
higher degree of plastic deformation prior to failure while 
the elastin hybrid constructs were more likely to fail through 
"brittle" failure modes. The energy ratios in both the col- 10 
lagen control samples (p<0.32) and elastin hybrid samples 
(p<0.996) remained essentially unchanged between the eight 
and twenty-three culturing time points. 
Viscoelastic Testing 
While conventional test-to-failure assays such as burst 
15 
pressure and uniaxial tensile testing can provide important 
information in terms of the overall strength of a material, 
they fail to capture the time-dependent behaviors known as 
viscoelasticity. Although a majority of materials have his-
20 
torically been simplified down to their idealistic counter-
parts, no true material behaves completely like either a 
Hookean solid or a Newtonian fluid under all temperature, 
stress, and strain levels. Biological tissues, including liga-
ments, skin, and arteries, are good examples of materials that 
25 
behave as both a viscous fluid and an elastic solid. Step 
stress relaxation and creep analysis were preformed in these 
experiments to characterize the viscoelastic properties of 
elastin hybrid and collagen control constructs seeded with 
either HDFs or RASMs. The extremely thin walls of the 
30 
HDF control constructs after twenty-three days of culture 
complicated the viscoelastic characterization. Consequently, 
data was discarded in cases where these specimens were 
obviously damaged during sample preparation. 
In the creep testing experiments, the applied mechanical 
35 
load was set equal to one third of the estimated ultimate 
tensile stress of each construct. In the stepwise stress relax-
ation experiments, five discrete strain displacements were 
introduced to each sample at six minute intervals. Burger's 
four element mechanical model was fit to the data and used 
26 
showed no significant difference at day twenty-three 
(p<0.90). The elasticity parameter R2 represents the degree 
of strain that occurs during the transient region and was 
58.5-fold (p<0.0001) and 16.6-fold (p<0.015) higher in 
elastin hybrid samples after eight and twenty-three days of 
culturing, respectively. The elastin scaffold also affected the 
coefficient of viscosity 11 2 which defines the length of the 
transient region. This parameter was 13.0-fold larger at day 
eight (p<0.0001) and 6.7-fold larger at day twenty-three 
(p<0.03) when elastin scaffolds were added to the con-
structs. The second coefficient of viscosity 11 1 represents 
unrecoverable strain that occurs at long time points. Again, 
elastin hybrid samples exhibited higher 11 1 coefficients with 
504-fold (p<0.0001) and 83-fold (p<0.0001) larger values 
versus collagen control samples at days eight and twenty-
three. 
Burger's model also provided a good fit of the creep 
behavior in both the elastin hybrid and collagen control 
samples seeded with RASMs with average R2 values of 
0.879 and 0.976, respectively. The moduli of elasticity and 
coefficients of viscosity of the modeled RASM creep experi-
ments are shown in FIG. 17. The elasticity parameter R1 was 
statistically unchanged in elastin hybrid and collagen control 
samples after both eight (p<0.30) and twenty-three (p<O. 15) 
days of culturing. The elasticity parameter R2 , on the other 
hand, was 16.2-fold (p<0.003) and 34.2-fold (p<0.0007) 
higher in elastin hybrid samples after eight and twenty-three 
days of culturing, respectively. Likewise, the coefficient of 
viscosity 11 2 was generally higher (2.7-fold at Day 8, p<0.07 
and 5.3-fold at Day 23, p<0.015) when elastin scaffolds were 
added to the constructs. 
Finally, elastin hybrid samples exhibited higher 11 1 coef-
ficients with 239-fold (p<0.002) and 143-fold (p<0.002) 
higher values versus collagen control samples at days eight 
and twenty-three. This last parameter is especially important 
in that it describes long-term creep phenomena. As 11 1 
increases towards infinity, the constructs exhibit less and less 
sustained strain until the deformation becomes essentially 
negligible. At this point, the 11 1 dashpot can be eliminated 
to elicit quantitative viscoelastic parameters. 40 reducing Burger's viscoelastic fluid model to the Standard 
Viscoelastic Solid. 
Creep Analysis 
Typical creep behavior profiles for elastin hybrid and 
collagen control samples are illustrated in FIG. 15. Even 
under the larger mechanical loads, constructs containing an 
intact elastin scaffold experienced less overall strain than the 
collagen controls. Immediately following the introduction of 
the mechanical load, both sample types endured some 
degree of instantaneous strain which was followed by a 
transient region in which the rate of strain slowed to quasi-
steady values. In the elastin hybrid samples, this transient 
decay occurred relatively quickly as the strain rates dropped 
to near zero values. The collagen control samples experi-
enced longer transient regions which eventually declined to 
steady, non-negligible rates of strain. These steady strain 
rates were capable of deforming the samples until failure 
eventually occurred and occasionally resulted in the prema-
ture termination of the control creep experiments. 
Burger's model provided a good fit of the creep behavior 
in both the elastin hybrid and collagen control samples 
seeded with HDFs with high average R2 values of0.871 and 
0.984, respectively. The moduli of elasticity and coefficients 
of viscosity of the modeled HDF creep experiments are 
shown in FIG. 16. The elasticity parameter R1 represents 
instantaneous deformations resulting from step load 
increases and was 15.0-fold (p<0.045) higher in elastin 
hybrid samples than collagen controls at day eight but 
While the elastin scaffold treatment clearly had a signifi-
cant impact on the viscoelastic creep parameters at almost 
every level, the length of culturing did not play as big a role 
45 in defining the creep behavior of the constructs. In the case 
of collagen control constructs seeded with HDFs, the p-val-
ues between the data collected at days eight and twenty-
three were above 0.51 for R1 and R2 of Burger's model. The 
p-values of11 1 and11 2 were more notable-0.026 and 0.072, 
50 respectively. These differences are likely to be related to 
construct compaction which altered thickness of the con-
struct walls between days eight and twenty-three. There 
were no statistical differences between the two time points 
in elastin hybrid constructs seeded with HDFs. With the 
55 exception of 11 2 which had a value of 0.35, the remaining 
parameter p-values were all above 0.84. In control con-
structs containing RASMs, the p-values between the data 
sets collected at the eight and twenty-three time points 
exceeded 0.59 for all four Burger's model parameters. 
60 Similarly, the p-values between the data sets collected for 
elastin hybrid RASM samples at the two times were above 
0.20 for R2 and11 2 and above 0.79 for R1 and11 1 of Burger's 
model. 
65 Stress Relaxation Analysis 
Stress relaxation characterization performs the inverse 
analysis of the creep tests and was used to complement the 
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viscoelastic strudies. By examining the results of both the 
creep and stress relaxation tests, it was possible to identify 
any inconsistencies which may have resulted from anoma-
lies introduced in the testing protocols or from selection of 
unsuitable mechanical models. The stress relaxation 5 
28 
The p-values comparing the initial and relaxed moduli data 
sets of HDF-seeded elastin hybrids at eight and twenty-three 
days were 0.405 and 0.555, respectively. The equivalent 
values were 0.084 and 0.161 for RASM-seeded elastin 
hybrids. For collagen control constructs containing HDFs, 
the p-values were 0.044 and 0.005. Similarly, they were 
0.109 and 0.084 for RASM collagen control samples. With 
the exception of HDF collagen control constructs, these 
differences did not achieve statistical significance. 
Although the initial and relaxed moduli are excellent 
indicators of important stress relaxation behaviors of these 
vascular grafts, the time dependent stress-strain data can also 
be fit to mechanical models to obtain quantitative viscoelas-
tic descriptions over the entire range of testing. The remain-
mechanical profiles were markedly different between col-
lagen control and elastin hybrid samples as illustrated in 
FIG. 18. The relatively modest increases in stress which 
accompanied the step displacements of the control con-
structs rapidly decayed to approximately 25% of its original 10 
value. This remaining stress continued to decrease slowly 
over the subsequent six minutes at which point the test was 
repeated. The step displacements of the elastin hybrid con-
structs were accompanied by a more substantial jump in 
stress. Following the displacement, this stress dropped 
slightly to a steady-state, sustained level. 
15 der of this section describes the stress relaxation behavior of 
the elastin hybrid and collagen control constructs utilizing 
the Burger's four element model. While the model simulated 
the stress relaxation data reasonably well, the fits were not 
as good as in the creep experiments. Although satisfactory 
Initial stress relaxation moduli were calculated from 
stress-strain relationships of the ring samples immediately 
following each step displacement and were affected by both 
the viscous and elastic natures of the samples. Relaxed stress 
relaxation moduli were calculated from stress-strain data six 
minutes after each step displacement-just before the sub-
sequent strain step. In these parameters, the transient viscous 
effects of the construct samples were assumed to have fully 
decayed leaving only the elastic components to bear the 
mechanical loads. 
20 solutions were identified which matched the requirements of 
the model, the fits generally did not extend to the stress 
levels immediately following the step displacement. Like-
wise, the models stress predictions dropped towards the zero 
level somewhat ahead of the experimental data. The overall 
25 fit, however was relatively good and it is likely that one 
would need to move to a model with additional or nonlinear 
In constructs seeded with HDFs, the initial moduli 
jumped 5.6-fold (p<0.0001) when collagen control samples 
were reinforced with elastin scaffold supports and cultured 
for eight days and 3.9-fold (p<0.0002) when cultured for 30 
twenty-three days as shown in FIG. 19. These findings are 
consistent with the uniaxial tensile test data presented pre-
viously which found higher moduli in elastin hybrid con-
structs than in collagen control constructs. The differences 
between the relaxed parameters, shown in FIG. 20, were 35 
even larger as inclusion of an elastin scaffold elicited 26.0-
fold p<0.0001) and 17.6-fold (p<0.0001) increases in the 
relaxed moduli at days eight and twenty-three respectively. 
Again, constructs seeded with RASMs had similar stress 
relaxation behaviors as those described for the HDFs. See 40 
FIGS. 21 and 22. When intact elastin scaffolds were incor-
parameters to obtain more accurate representations of the 
data. 
The moduli of elasticity and coefficients of viscosity for 
constructs containing HDFs and RASMs as described using 
Burger's model are illustrated in FIGS. 25 and 26, respec-
tively. The mean observed R1 elasticity parameters which 
represents the stress resulting from the instantaneous strain 
steps were 4.2-fold (p<0.025) and 2.9-fold (p<0.14) higher 
in HDF elastin hybrid samples and 2.3-fold (p<0.28) and 
2.9-fold (p<0.005) higher in RASM elastin hybrid samples 
than collagen controls after eight and twenty-three days of 
culturing, respectively. The elasticity parameter R2 which 
represents the drop in stress levels in the time shortly 
following each strain jump was 64.0-fold (p<0.0001) and 
13.7-fold (p<0.0001) higher in elastin hybrid samples con-
taining HDFs and 16.2-fold (p<0.0007) and 17.0-fold 
(p<0.0003) higher samples containing RASMs after eight 
and twenty-three days of culturing, respectively. The elastin 
porated into the constructs, the initial moduli jumped 4.5-
fold (p<0.0005) and 5.1-fold (p<0.006) at days eight and 
twenty-three, respectively. The relaxed modulus increased 
even further as elastin hybrid samples containing RASMs 
were 16.7-fold (p<0.013) and 17.8-fold (p<0.015) stiffer 
than control samples after eight and twenty-three days of 
static culture, respectively. 
45 scaffold also affected the 11 2 coefficient of viscosity which 
helps define the length of the region during which rapid 
relaxation of stress occurs. The 11 2 of constructs seeded with 
HDFs increased 324-fold at day eight (p<0.0001) and 
73-fold at day twenty-three (p<0.0001) when elastin scaf-Ratios of the two stress relaxation moduli were used to 
help identify the nature of the mechanical properties that 
each construct possessed. As seen in FIGS. 23 and 24, the 
high ratios of the initial modulus to relaxed modulus in 
collagen control constructs indicated that the majority of 
their resistance to deformation stemmed from their highly 
viscous fluid-like natures. Conversely, the initial to relaxed 
modulus ratios of the elastin hybrid constructs were close to 
one indicating that their mechanical properties tended to 
result from their elastic natures. In every case examined, 
collagen control constructs had higher ratios of stress relax-
ation moduli than the elastin hybrid constructs (HDF: 4.4- 60 
fold higher, p<0.0001 at Day 8; 4.6-fold higher, p<0.0001 at 
Day 23; RASM: 3.1-foldhigher, p<0.0001 at Day 8; 3.3-fold 
higher, p<0.0001 at Day 23). 
As in the creep analysis, differences in the stress relax-
ation behaviors between the elastin hybrid and collagen 
control samples were much greater than differences that took 
place with the duration of culturing or between cell types. 
50 folds were added. The 11 2 of constructs seeded with RASMs 
increased 37.8-fold at day eight (p<0.0006) and 24.8-fold at 
day twenty-three (p<0.0003) when elastin scaffolds were 
added. The 11 1 coefficient of viscosity describes the rate the 
stress decays to zero once after the transient drops have 
55 ended. Again, elastin hybrid samples exhibited higher 11 1 
coefficients with 784-fold (p<0.0001) and 91-fold 
(p<0.0001) increases for HDFs and 110-fold (p<0.0001) and 
95-fold (p<0.0001) increases for RASMs at days eight and 
twenty-three. 
The duration of culturing did not have a large effect on the 
viscoelastic parameters of the constructs. There were no 
statistically significant differences between the eight and 
twenty-three day data sets in collagen control constructs 
seeded with HDFs. While the p-values for 11 1 and R2 were 
65 0.38 and 0.68, respectively, the values for the other two 
parameters were greater than 0.90. Elastin hybrid constructs 
seeded with HDFs exhibited similar behaviors with p-values 
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for all four mechanical parameters greater than 0.90. In 
control constructs containing RASMs, the p-values between 
the data sets collected at the eight and twenty-three time 
points exceeded 0.59 for all four Burger's model parameters. 
Similarly, the p-values between the data sets collected for 
elastin hybrid RASM samples at the two time points were 
above 0.4 for 11 1 , R2 , and 11 2 . In the case of R1 , the p-value 
parameter was 0.037 though it is not obvious why the 
parameter was so low. 
Constructs that mimic native arterial structure and physi-
ology will be more successful in maintaining long-term 
vascular function. Pericellular biochemical signals between 
the SMC and endothelial cells helps to regulate vasodilation 
and intima behavior. Additionally, significant ingrowth and 
integration of the elastin and collagen layers are necessary to 
ensure that the multi-component system will function as a 
single, intact composite structure. This integration will pro-
ceed as cells infiltrate the elastin scaffold and deposit new 
matrix between the lamellar layers. 
Minimal cell ingrowth into the elastin layers, however, 
was observed in the isolated scaffold experiments. This 
could be due in part to low permeability of the elastic 
structures. Since elastin exists predominantly as concentric, 
lamellar sheets, cells must circumnavigate around the plies 
in order to infiltrate the structure. While this may present a 
seemingly sizable obstacle, nutrient diffusion gradients are 
another likely cause for the lack of observed ingrowth. Cell 
proliferation and migration has been linked to concentration 
gradients of oxygen, nutrients, and growth factors. Since the 
constructs were cultured upon an impermeable glass man-
drel, the nutrient supply predominantly came from the 
outside. Consequently, it is not surprising that the highest 
cell densities were seen concentrated on the outermost layer 
of the constructs and cells on the inside of the constructs 
may have died of starvation. It may be possible to reduce or 
even reverse the outward migration by feeding the cells from 
both sides of the construct wall. Doping the lumenal media 
with excess serum or chemotactic factors may further aug-
ment these effects. An alternative solution could directly 
seed cells between the elastin layers using a syringe or 
similar device. Once placed in the desired locations, the cells 
should be able to synthesize matrix proteins and enhance the 
levels and rates of integration between the components of 
the hybrid constructs. 
Calcification has been associated with elastin and elastic 
fibers and is often implicated in impaired performance of 
aortic and heart valve tissues. Some recent studies have 
indicated that microfibrillar proteins and not elastin itself 
may be responsible for calcium formation since the deposits 
typically form near the outside of the elastic fibers. Increases 
in calcium contents often coincide with high concentrations 
30 
allogenic and xenogenic materials introduce the potential for 
immunological responses. In general, extracellular matrix 
proteins are likely to elicit fewer immune rejection 
responses than cells and cellular components which contain 
major histocompatibility complex (MHC) molecules. 
Bovine and rat collagens have been used clinically in 
cosmetic applications with relatively few immunological 
complications. The site of the implantation, however, may 
play an important role in the resulting immune response. 
10 While xenogenic collagen may perform acceptably in the 
subcutaneous regions of the face, it is unclear whether the 
collagen can function in the hostile environment of the 
vasculature. If it does turn out that allogenic collagen is 
necessary for success in vascular grafts, human collagen can 
15 be isolated from human cells growing in culture. Isolated 
elastin scaffolds, on the other hand, may not be as suited for 
allogenic therapies. While some cadaveral arteries are likely 
to be available from tissue donors, shortages similar to those 
experienced with organ transplantation can limit large-scale 
20 production. Fortunately, while some differences between 
human and porcine elastins exist, the overall homology 
between the proteins is relatively high. 
Cells present a larger challenge to implantation from an 
immunological perspective. Of the various cell types found 
25 in native arteries, fibroblasts are the most immune compat-
ible and have been successfully used in allogenic skin graft 
products such as Dermagraft (Advanced Tissue Sciences, 
LaJolla, Calif.). Smooth muscle cells evoke somewhat mod-
erate responses, but endothelial cells are extremely immu-
30 nogenic. Use of autologous endothelial cells has been 
reported. Potential autogenic strategies include ECs from the 
microvasculature of adipose tissue or circulating ECs iso-
lated from blood samples. Stem cells, both mesenchymal 
and embryonic, have also been proposed as alternative 
35 sources for immunocompatible endothelial cells. A final 
strategy attempts to modify privileged cells to mimic cells in 
the endothelium. The current theories are that allogenic 
SMC and fibroblasts should be acceptable while one of the 




De Novo Elastin Studies 
One strategy used to explore the effects of elastin on 
vascular constructs utilized de nova elastin expression. 
Genetic manipulation of cells with no or low native expres-
sion levels were additional methods of stimulating elastin 
50 production. The following Examples describe the methods 
used to genetically engineer recombinant elastin expression 
and some of the experiments conducted using these and 
native expressing cells in two dimensional monolayers and 
three dimensional constructs. 
of acidic and polar amino acids. Glutamic acid and aspartic 
acid residues, which are frequently linked with calcification, 
constitute up to 10% of the fibrillin protein. Furthermore, 
fibrillin contains forty-three calcium-binding consensus 55 
sequences. If the microfibrillar proteins and not elastin are 
responsible for calcification of elastic fibers, then a digestion 
procedure which removes all non-elastin proteins from the 
matrix (like the one used in these isolated elastin scaffold 
studies) may reduce calcification in the tissue. 60 
In this method, cells are selected based upon their ability 
to express high levels of a target protein or based upon their 
capacity for genetic modification and recombinant overex-
pression. This method provides pericellular deposition of a 
matrix which could then be assembled on a cellular level. 
Experiments involving de nova elastin production were 
studied to ascertain some of the possibilities and limitations 
of this approach. Plasmid expression vectors were con-
structed and transfected into NIH/3T3 murine fibroblasts 
and HDFs for recombinant elastin production. Rates of 
elastin synthesis were evaluated at the mRNA and tropoelas-
tin levels on cells growing in monolayers and three-dimen-
sional collagen constructs. Some additional studies involv-
Species Heterogeniety 
The species heterogeneity between the matrices and cells 
used in these isolated elastin scaffold experiments created an 
additional issue. While tissue engineered devices possess 65 
theoretical advantages over synthetic approaches which will 
typically elicit some degree of foreign body responses, 
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ing cell proliferation and construct compaction were 
performed to identify potential secondary effects of genetic 
modification on cellular function. 
pIRES-Elastin Vector 
The pIRES-elastin expression vectors were constructed to 
induce overproduction of elastin in genetically modified 
cultured cells. A plasmid containing the cDNA for human 
tropoelastin was obtained from Dr. Joel Rosenbloom at the 
University of Pennsylvania Restriction enzyme mapping 
10 
revealed the gene to be a -2.2 kb molecule with EcoRI and 
Neal sites at the 5' end and EcoRI and Xbal sites at the 3' 
end. The pIRES-lneo plasmid, shown in FIG. 27, (Clontech, 
Palo Alto, Calif.), has a single EcoRI site in its multicloning 
site (MCS) just downstream of a human cytomegalovirus 
15 
promoter (P cMv) and was selected as a bicistronic expres-
sion vector for elastin production. 
Plasmid Construction 
32 
and regrown in LB media containing ampicillin (100 µg/ml) 
for plasmid analysis. Competent cells receiving known 
quantities of a standard plasmid solution and blank DNA-
free solutions were used as positive and negative controls for 
each experiment. High quality reagents and meticulously 
cleaned glassware were used to help maximize the compe-
tency of the bacteria cultures. 
Plasmid Analysis and Gene Sequencing 
Plasmids isolated from transformed bacteria using a DNA 
purification kit (Amersham Pharmacia Biotech) were 
assessed by restriction enzyme mapping to screen trans-
fected colonies. Purified plasmids were added to individual 
and multiple combinations of restriction enzymes (New 
England Biolabs) buffered according to the manufacturer's 
recommendations and incubated in a 37° C. water bath for 
90 min. After the addition of bromophenol loading buffer, 
the enzyme digests were loaded into an agarose/ethidium 
bromide gel and run in TAE buffer at 120 V for 60 min. An 
The pIRES-elastin vector, shown in FIG. 28, was con-
structed using restriction enzyme digestion, agarose gel 
electrophoresis separation, and religation procedures. 
Human tropoelastin cDNA and pIRES-lneo expression 
plasmids were transformed into competent jml 09 E. coli 
bacteria. Plasmid DNA was isolated from transformed bac-
teria using a Sephaglas™ FP purification kit (Amersham 
Pharmacia Biotech, Peapack, N.J.) and stored at -20° C. To 
construct the pIRES-elastin constitutive expression plasmid, 
the tropoelastin cDNA plasmids were digested with EcoRI 
restriction enzymes (New England Biolabs, Beverly, Mass.) 
20 
UV transilluminator was used to visualize the DNA bands, 
and images were captured on Polaroid film or digitally via 
a CCD camera. Once a plasmid had been determined to 
contain the elastin cDNA gene in the correct orientation, the 
plasmid was sequenced to test for mutations and misincor-
25 porated nucleotides. 
at 3 7° C. for 60 min. Bromophenol loading buffer was added 30 
to the tropoelastin digest, and the cDNA was electrophore-
sed in a 1 % low melting point SeaPlaque GTG agarose gel 
(Cambrex Corporation, East Rutherford, N.J.) containing 
0.5 µg/ml ethidium bromide. The gels were run in a hori-
zontal electrophoresis apparatus (Gibco BRL) using a low- 35 
EDTA Tris-acetate (TAE) buffer. As the samples were visu-
alized under an UV transilluminator, the band corresponding 
to tropoelastin cDNA was cut out with a flame-sterilized 
blade. The agarose embedded DNA was melted at 65° C. for 
Example 6 
Introduction of DNA into Mammalian Cells 
The pIRES-elastin plasmids were transfected into the 
nuclei of eukaryotic cells using liposomal-mediated and 
lipid-based delivery systems. Murine NIH/3T3 fibroblasts 
were transfected using LipofectAMINE cationic liposomes 
(Clontech) and cultured under geneticin selective pressure to 
produce stable clones. HDFs were transfected via the 
FuGENE™ 6 lipid delivery reagent (Roche Diagnostics 
Corporation, Indianapolis, Ind.) and cultured without selec-
tive pressure to produce transiently modified cells. 
NIH/3T3s were cultured in supplemented DMEM to 75% 
confluency on tissue culture plastic as previously described. 
Liposomes were constructed by combining 100 µg of Lipo-
fectAMINE transfection reagent with -60 µg of pIRES-
elastin plasmid DNA in 30 ml of serum-free DMEM media. 
Cells were rinsed in PBS to remove serum proteins which 
can interfere with the transfection and incubated in the 
liposome/DNA media for 2 to 4 hours to ensure plasmid 
uptake. They were then rinsed again in PBS to remove the 
liposome complexes which could eventually cause cytotox-
icity and returned to standard culturing conditions for recov-
15 min and digested in ~-agarase (New England Biolabs) 40 
according to the manufacture's recommendations. The 
pIRES-lneo plasmid was also digested with EcoRI restric-
tion enzymes followed by incubation in calf intestinal alka-
line phosphatase (CIP) to remove the 5' phosphate groups 
thus preventing self-ligation. The pIRES-lneo plasmid was 45 
combined with the tropoelastin cDNA and ligated with high 
concentration T 4 DNA Ligase (New England Biolabs) over-
night in a cold water bath to create the pIRES-elastin 
expression plasmid. 
50 ery. Geneticin antibiotic (G418) (Gibco BRL) was added to 
the media at a concentration of 500 µg/ml twenty-four to 
seventy-two hours following the transfection to select for 
stable transformants. G418 interferes with a cell's ability to 
express proteins and consequently kills any cell which has 
E. Coli Transformation and Plasmid Amplification 
Plasmid DNA was transformed into competent jm109 E. 
coli bacteria for selection and amplification. Bacteria cul-
tures in the state of active growth were made competent with 
transformation buffer (TFB) and stored on ice for up to 72 
hours before being used. Plasmid DNA was added to the 
competent cells in a 1 :20 (v:v) ratio, and the solution was 
stored on ice for 20 to 30 minutes. The solution was heat 
shocked in a 42° C. water bath for exactly 90 seconds and 
then chilled on ice for 2 minutes. Luria-Bertani (LB) media 
was added to the bacteria solution in a 4:1 (v:v) ratio, and the 
cultures were incubated at 37° C. for an hour to allow the 
bacteria to recover and express the ampicillin resistance 
marker. The transformant cell solution was then spread over 
the surface of LB agar culture plates containing 100 µg/ml 
ampicillin. After 24 hours incubation at 37° C., newly 
formed colonies growing on the agar plates were isolated 
55 not properly incorporated the plasmid DNA encoding for 
antibiotic resistance into its genetic structure. 
HDFs were cultured in supplemented DMEM to 75% 
confluency on tissue culture plastic as previously described. 
Transfection complexes were formed by adding plasmid 
60 DNA (1 µg per 3 µl FuGENE reagent) to a 3% FuGENE 6, 
serum-free DMEM solution (v:v) in a sterile microcentri-
fuge tube. The contents of the tube were gently mixed and 
incubated at room temperature for 20-25 minutes. The 
complex mixtures were then added dropwise to the cell 
65 culture flasks (0.125 µg DNA per cm2 growth area) and 
incubated for 24-48 hrs. One of the advantages associated 
with using this lipid delivery system was the ability to use 
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serum protein supplements during the transfection process. 
This decreased cytotoxicity complications and allowed for 
extended transfection complex incubations. Following the 
incubations, the growth media was replaced. Transfected 
HDFs were typically evaluated under transient expression 
culture conditions 2-5 days following transfection. 
Example 7 
34 
mid DNA was collected from the two colonies with the 
correct tropoelastin orientation and sequenced at Loftstrand 
Labs using the Sanger method and at the Emory DNA 
Sequencing Facility using dye terminator cycle sequencing 
methods with fluorescently tagged nucleotides. 
As described, pIRES-elastin plasmids were transfected 
into NIH/3T3 fibroblasts and passage 5-7 HDFs using 
cationic liposome-mediated and lipid-based transfection 
De Novo Expression Experiments 
Monolayer experiments were employed to investigate 
levels of elastin expression in native and genetically modi-
fied cells. Unless indicated otherwise, cells were cultured on 
treated tissue culture plastic. When growth factors were 
utilized, they were administered as soluble constituents in 
the culture media. Two dimensional investigations were 
generally conducted as destructive experiments at fixed end 
points. 
10 
delivery systems, respectively. Transfected NIH/3T3s were 
cultured in DMEM supplemented with 10% calf serum and 
500 µg/ml G418 antibiotic to select cells displaying stable 
plasmid expression. The concentration of G418 was deter-
mined using a dose response curve. At levels above 300 
15 
µg/ml, all unmodified 3T3s died within 72 hrs following the 
introduction of the antibiotic. When grown under 500 µg/ml 
G418 selective pressure, the majority of transfected NIH/ 
3T3s died off within six to seven days. This indicated that a 
fairly low percentage of cells had incorporated the plasmid. 
20 ~~~~;~~ ~~~~~:: :e::~~~~~:~~ T~::!~i~i~~i~~~~~t:~~t:~ Three dimensional experiments were employed to inves-tigate the production rates and structural orgarization of 
elastin in collagen-based constructs. When genetically 
modified cells were used, they were generally transfected 
while still in monolayer culture. Following transfection, the 
cells were suspended distributed into collagen gels as pre- 25 
viously described. This provided for increased control in 
determining cell populations, regulating growth phases, and 
standardizing transport delivery rates. Specific assays were 
used to characterize cell and construct functionality. 
these cells indicated that they had incorporated the plasmids 
into their chromosomal DNA. 
Recombinant HDFs were cultured under transient condi-
tions in the standard FBS supplemented DMEM media 
described previously. By using a lipid-based delivery system 
which remains functional in the presence of serum proteins, 
it was possible to minimize cytotoxicity. Additionally, the 
lipid-based system did not appear to adversely affect the 
30 HDF transfection efficiency compared to the cationic 
liposme-mediated system as demonstrated by slightly 
elevated reporter enzyme activity levels when cells were 
transfected with the pGL3-Control luciferase vector. Tran-
sient expression in recombinant HDFs was utilized to mini-
As described previously, the cDNA encoding the human 
tropoelastin gene was incorporated into pIRES- lneo bicis-
tronic mammalian expression vector for recombinant elastin 
production. Following EcoRI digestion and agarose gel 
electrophoresis purification, the -2.2 kb tropoelastin seg-
ments were ligated into dephosphorylated EcoRI sites in the 
MCS of the expression plasmid. Dephosphorylation was 
used to reduce the chances of religation in the pIRES- lneo 
plasmids. Following the construction of the pIRES-elastin 
plasmids, jml 09 E. coli bacteria were transformed with the 
newly made vectors and grown into distinct colonies on agar 40 
plates under ampicillin selective pressure. The ampicillin 
eliminated all bacteria that were not properly transformed 
with an intact vector but did not distinguish between the 
plasmids which contained the target gene and those that did 
not. 
35 mize cell passaging effects which would have accompanied 
the stable clone selection process. Analogous populations of 
untransfected cells and cells transfected with the unmodified 
pIRES-lneo plasmid were examined for comparison. 
Competitive RT-PCR analysis revealed a marked increase 
in tropoelastin mRNA levels in cells transfected with 
pIRES-elastin as compared to untransfected or pIRES-lneo 
transfected controls. All of the fifteen NIH/3T3 colonies 
examined exhibited a strong band following PCR indicating 
that they were producing tropoelastin mRNA. No bands for 
45 tropoelastin could be visualized in NIH/3T3 control samples 
after 28 PCR cycles. While basal levels of tropoelastin 
mRNA were discernible in unmodified nHDF, transfection 
with the pIRES-elastin vector was able to increase the 
Since EcoRI sites existed at both the 5' and 3' ends of the 
tropoelastin cDNA, the gene was able to ligate into the 
pIRES-lneo vector in either the forward or reverse direc-
tions, as shown in FIG. 29. When plasmid vectors containing 
tropoelastin DNA in the correct orientation were digested 50 
with Neal restriction enzymes, three segments with lengths 
of 324, 3388, and 3741 basepairs formed. When plasmid 
vectors containing tropoelastin DNA in the incorrect orien-
tation were digested with Neal restriction enzymes, three 
segments with lengths of 1541, 2524, and 3388 basepairs 55 
formed. Individual jml 09 colonies growing on the agar 
plates were screened via Neal restriction enzyme mapping 
mRNA production level by several orders of magnitude. 
Monolayers of NIH/3T3s jumped from undetectable lev-
els of mRNA expression to 92,500 copies/µg total RNA 
following stable transfection, see FIG. 30. Similarly, tro-
poelastin mRNA expression in transiently transfected mono-
layers ofHDFs increased from below 18,000 to 58,000,000 
copies/µg total RNA (p<0.001 vs. Untransfected HDFs, 
p<0.001 vs. FuGENE-6 Mock-transfected HDFs, p<0.001 
vs. pIRES-lneo Mock-transfected HDFs) forty-eight to sev-
enty-two hours following transfection. 
60 Cellular Function of Transfected NIH/3T3s and HDFs 
to identify colonies producing pIRES-elastin plasmids with 
the proper gene orientation. Based on restriction enzyme 
digestion, the colonies in lanes five, six, and seven appear to 
have incorporated the tropoelastin cDNA in the incorrect 
orientation. Similarly, the colonies in lanes three and four 
appear to have incorporated the cDNA into the plasmid in 
the correct orientation. Lanes one and two contain Neal 
digests of pElastin and pIRES- lneo plasmids which were 65 
used as controls. The Lambda-BstEII molecular weight 
ladder (New England Biolabs) was run in lane eight. Plas-
Various types of cellular functionality were assessed on 
transfected NIH/3T3s and HDFs grown in both monolayer 
and three dimensional collagen structures to identify pos-
sible secondary effects associated with genetic recombina-
tion. NIH/3T3s were characterized for cell proliferation and 
construct gel compaction. HDFs were characterized for 
construct gel compaction and expression stability. 




Fibrin and fibrin-collagen constructs were prepared. 
Briefly, fibrinogen and E-amino caproic acid (ACA) were 
combined with thrombin and FBS and RASMs in DMEM 
culture media containing penicillin (100 IU/ml) and strep-
tomycin (100 µg/ml) to form fibrin gels. These gels were 
Analysis of NIH/3T3 monolayers indicated that cells 
transfected with pIRES-elastin divided at slower rates and 
were less likely to grow in multiple layers than their untrans-
fected counterparts. When seeded at subconfluent condi-
tions, transfected fibroblasts in G418 supplemented media 5 
grew slower compared to unmodified cells (Transfected 
w/G418--47.1 hr/doubling vs. Untransfected-19.1 hr/dou-
bling, p<0.0001 ). The division time of the transfected cells 
dropped to 36.6 hr/doubling when the antibiotic selective 
pressure was removed (p<0.08 vs. Transfected w/G418) but 
still remained significantly lower than in the unmodified 
controls (p<0.0001 vs. Untransfected). Populations of both 
transfected and untransfected cells seeded under highly 
confluent conditions showed little or no division and may 15 
have even decreased slightly in number over the course of 
seven days. 
10 
constructed in the same tubular molds as the standard 
collagen-based constructs and initially contained 2 mg/ml 
fibrinogen, 2 mg/ml ACA, and 0.2 U/ml thrombin. The 
tubular molds were sealed with ventilated caps and incu-
bated at 37° C. for 30 minutes. Once the fibrin had poly-
merized, the gels were removed from the molds and cultured 
in complete DMEM growth media containing 2 mg/ml ACA 
and an additional 0.292 mg/mL (2 mM) L-glutamine. ACA 
was added as an inhibitor of the Lys-Plasmin and Glu-
Plasmin enzymes that are released by the cells and can 
Genetic modification also affected the abilities of NIH/ 
3T3s to compact collagen gels. When seeded into 2 ml disk 
constructs at lxl06 cells/ml and cultured for eleven days, 
unmodified NIH/3T3s were able to remodel and compact 
their surrounding matrix, but to a lesser extent than unmodi-
fied HDFs. This capacity for gel compaction decreased even 
further when the NIH/3T3s were transfected with the 
20 
degrade fibrin. L-glutamine is an energy and carbon source 
used by most cells (Freshney 2000) and was a standard 
additive in Cummings' experiments that was used to supple-
ment the 4 mM L-glutamine present in the DMEM. 
Mixed Gels 
Mixed gels containing combinations of fibrin and col-pIRES-elastin plasmid. FIG. 31 shows the gel compaction 25 
data as assessed by the ratio of wet weight to dry weight. As 
the constructs developed, the edges of the disk compacting 
gels frequently curled up. This made an estimation of 
compaction using dimensional analysis difficult. 
Since the combined dry weight of the collagen matrix and 
cellular components remained relatively constant through-
out the eleven days of culturing while the wet weight was 
determined primarily by the fluid contained in the gel, this 
ratio could be used to estimate the volume of each disk 35 
construct regardless of its geometry. The wet weight to dry 
weight of unmodified NIH/3T3s was 1.27-fold higher than 
lagen were also examined as scaffold matrices. These con-
structs were constructed to contain equivalent initial con-
centrations of fibrin (2 mg/ml) and collagen (2 mg/ml). All 
constructs were statically cultured six days prior to analysis 
30 on adherent silicon tubes. The silicon tubes provided a 
distensible inner barrier which could be cyclically inflated 
during experiments involving mechanical conditioning. 
Example 9 
Collagen-Based Construct Sleeve Hybrids 
The present invention can be made with synthetic support 
structures such as Dacron sleeves to provide mechanical 
integrity to collagen gel constructs, this embodiment uses 
collagen-based support structures. Crosslinking was also 
investigated as a means of further augmenting the mechani-
cal strength and stability of the constructs. 
in HDFs (p<0.001 ). The same ratio in stably transfected cells 
was 1.81-fold higher than in HDFs (p<0.001) and 1.42-fold 
higher than in unmodified NIH/3T3s (p<0.001). All cell 40 
types, however, elicited statistically significant gel compac-
tion compared to acellular constructs (p<0.02 vs. Trans-
fected NIH/3T3s, p<0.003 vs. Unmodified NIH/3T3s, 
p<0.002 vs. HDFs). 
45 Sleeve Fabrication 
Acellular, biological support sleeves were fabricated 
using the glass capillary tube mandrel assemblies previously 
described. Rat collagen, DMEM, sodium hydroxide, and 
PBS (pH 7.4) were combined on ice to produce a solution 
Cellular function in transiently transfected HDFs incor-
porated into collagen disk constructs forty-eight hours fol-
lowing transfection was also affected by genetic modifica-
tion. Shown in FIG. 32, the degree and rate of gel 
compaction in the transfected constructs was less vigorous 
than in the control constructs. While unmodified cells pro-
duced large degrees of compaction in the initial hours 
following construct fabrication, the rate of change in area 
dropped off in ensuing days. Recombinant cells, on the other 
hand, compacted their surrounding matrices more slowly at 
first but gradually caught up with subsequent culturing. 
50 with a 2.0 mg/ml final collagen concentration. The solutions 
were poured into the glass test tube molds and transferred to 
a 37° C. incubator and incubated for 1 hr to ensure gelation 
of the collagen fibers. The acellular constructs were then 
carefully removed from the test tubes and dehydrated over-
55 night on a rotating metal rod. The rotation was necessary to 
ensure uniform drying of the sleeve. Sleeves were either 
used as such, i.e. uncrosslinked (UnXL), or following one of 
the crosslinking treatments described below. 
Stability of the plasmid expression in disk constructs 
seeded with transiently transfected HDFs is shown in FIG. 
33. During the twelve days of culturing, the observed mean 
tropoelastin mRNA levels dropped from 6.8xl 06 to 3.2xl 06 
copies/µg total RNA. While this change did not reach 
statistical significance (p<0.08), the trend indicated that 
some expression loss may be taking place. Even with the 
drop, however, the expression in recombinant HDFs 65 
remained 40.5-fold higher than in untransfected control 
constructs after twelve days of culturing (p<0.00 1) 
60 Glutaraldehyde Crosslinking (Glut) 
Sleeves were rinsed briefly in PBS to remove excess 
DMEM salts and amino acids and submerged in a PBS 
solution containing 0.5% glutaraldehyde (Sigma). Samples 
were incubated under gentle agitation overnight at 4° C. to 
ensure uniform crosslinking throughout the sample. The 
sleeves were then rinsed 3x in PBS followed by two 24 hr 
PBS washes at 4 ° C. to remove residual glutaraldehyde. 
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Dehydrothermal Crosslinking 
Sleeves subjected to dehydrothermal crosslinking (DHT) 
were placed in test tubes and crosslinked in a silica gel 
desiccator. Air was evacuated from the chamber with a Gast 
laboratory pump, (Gast Manufacturing, Benton Harbor, 5 
Mich.) and the desiccator was heated at 120° C. in an 
Econotherm Precision Scientific Laboratory Oven (Model 
1025) (Winchester, Va.)for either one (DHT-1 d) or five 




yellow discoloration of the collagen. The effects of UV 
treatment were more subtle as no observable changes were 
evident. 
Stress-strain profiles of all sample types revealed that the 
sleeves exhibit relatively linear behaviors in the circumfer-
ential orientation up to the point of catastrophic failure. 
Samples typically strained between 15-20% prior to reach-
ing their peak stresses. Crosslinking treatment augmented 
the mechanical properties of the support sleeves. 
Circumferential peak failure stresses of all crosslinked 
specimens were significantly higher than those of their 
uncrosslinked counterparts. The mean UTS of Glut sleeves 
increased 3.4-fold (p<0.002) versus control. UV-60 m and 
UV-120 m sleeves increased 2.0-fold (p<0.03) and 2.1-fold 
Sleeves subjected to ultraviolet crosslinking (UV) were 
irradiated in a Fisher Biotech™ Oven (FB-UVXL-1000, 
Fisher, Pittsburgh, Pa.) under a bank of five 8-watt UV lights 
operating at 254 nm. Samples were placed on sheets of 
aluminum foil and exposed for 60 min (UV-60m) or 120 min 
(UV-120 m). Each sleeve was rotated 90 degrees every 15 
min to facilitate uniform crosslinking. 
Hybrid Construct Formation 
15 (p<0.03) from control levels, respectively. DHT-1 and 
DHT-5 sleeves increased 2.8-fold (p<0.03) and 2.9-fold 
(p<0.006), respectively. The linear moduli stiffness param-
eter increased in all crosslinking treatment groups. The mean 
modulus of Glut sleeves increased 3.3-fold (p<0.005) com-
The formation of the CSH was accomplished using a 
modified version of the protocol described in Section 3.1.2. 
Acellular sleeves were washed briefly in PBS while still on 
the mandrel to remove excess DMEM salts and amino acids. 
Suspensions of HDFs and rat collagen were created as 
previously described and poured into the test tube molds. 
The mandrel assemblies containing the support sleeves were 
inserted, and the suspensions were gelled at 37° C. for 45 
minutes. Once gelled, the CSHs were removed from the 
molds and cultured statically in suspension petri dishes for 
20 pared to untreated controls. UV-60 m and UV-120 m sleeves 
increased 2.3-fold (p<0.002) and 3.3-fold (p<0.01), respec-
tively. DHT-1 and DHT-5 sleeves increased 3.1-fold 
(p<0.02) and 3.7-fold (p<0.001), respectively. While extend-
ing the duration of UV and DHT crosslinking tended to 
25 increase the mechanical parameters, variations within the 
UV and DHT treatment groups were not statistically sig-
nificant. 
8 or 23 days prior to analysis. As the cells remodeled their 30 
matrix, the cellular component of the CSH compacted about 
the inner support sleeve. Unreinforced constructs con-
structed without support sleeves were used as controls 
throughout the experiments. 
The direction the samples were oriented during analysis 
also affected the outcomes of the uniaxial tensile tests. When 
in a longitudinal (L) orientation, peak stresses of 
uncrosslinked (UnXL) support sleeves were 3.6-fold higher 
than the corresponding stresses of samples in a circumfer-
ential (C) orientation (C~3.0 MPa vs. L~l0.8 MPa, 
p<0.03). Likewise, linear moduli were 4.6-fold higher in the 
Collagen-Based Construct-Sleeve Hybrids (CSHs) 
The CSH grafts investigated consisted of dehydrated, 
crosslinked acellular sleeves surrounded by layers of col-
lagen embedded cells. The sleeves took advantage of find-
ings that linked the density of collagen and crosslinking 
treatment with increase strength. Glutaraldehyde incubation 
(Glut), dehydrothermal treatment (DHT), and ultraviolet 
irradiation (UV) were selected to identify appropriate meth-
ods of crosslinking the acellular sleeves. HDFs embedded in 
Type I rat collagen were used to fabricate the CSHs. CSH 
grafts were analyzed through collagen gel compaction 
assessment, histological and viability staining, and mechani-
cal testing. 
35 longitudinal direction than in the circumferential orientation 
(C~l 7 .9 MPa vs. L~81.9 MPa, p<0.01 ). While the statis-
tical correlations were not as strong, sleeves crosslinked 
with glutaraldehyde displayed similar trends with respect to 
axis orientation: Peak stresses (C~l0.2 MPa vs. L~14.9 
40 MPa, p<0.10); Linear moduli (C~59.8 MPa vs. L~181.1 
MPa, p<0.01). These results indicate that preferential align-
ment of collagen fibers takes place as the sleeve supports 
dehydrate on the glass mandrel. Additionally, it suggested 
that the mechanical properties may be further enhanced by 
45 controlling and optimizing the fiber orientation during 
sleeve formation. 
Acellular Collagen Support Sleeves 
Acellular sleeves were first examined without the cell- 50 
seeded components to determine which crosslinking treat-
ments might be most effective to use in the CSHs. During the 
dehydration process, the acellular collagen structures trans-
formed from three-dimensional, 3.75 mm thick hydrogels 
into thin paper-like sleeves which were approximately 50 55 
µm thick. As the moisture was removed, the gels experi-
enced a 99.7% reduction in weight. By allowing the ends of 
the gels to remain adherent to the mandrel stoppers, it was 
possible to induce essentially unidirectional radial compac-
tion thus creating sleeves with predictable final dimensions. 60 
Upon reintroduction to aqueous environments, the sleeves 
swelled slightly but maintained their macroscopic geom-
etries even after extended incubation periods (>6 weeks). 
While the various crosslinking treatments did not evoke 
statistically significant changes in the dimensions of the 65 
dehydrated sleeves, some alterations in physical appearance 
occurred. Both glutaraldehyde and DHT elicited a slight 
Based on the results of the sleeve support studies, glut-
araldehyde crosslinking was selected as a model treatment 
method for the subsequent CSH experiments. While all of 
the methods showed promise, the effects of glutaraldehyde 
were the most profound and consequently, could help to 
determine the upper limitations of a CSH approach to tissue 
engineering a vascular graft. 
Gel Compaction Data 
Following the addition of the second cell-seeded layer, the 
CSHs compacted rapidly in both the radial and longitudinal 
directions. After eight days of culture, uncrosslinked CSHs 
occupied less than 6% of their original volume. This remod-
eling process continued with time until only 3.2% of the 
original volume remained at day twenty-three. Crosslinking 
the sleeves with glutaraldehyde resulted in a significant 
decrease in compaction at day eight (Glut~7.4% vs. 
UnXL~5.6%,p<0.02),butbydaytwenty-threethecompaction 
levels were statistically indiscernible (Glut~3.8% vs. 
UnXL~3.2%, p<0.63). The wall thicknesses of the Glut and 
UnXL CSHs were analogous at both measured time points 
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(Day 8: Glut~.75 mm vs. UnXL~0.75 mm, p<0.999; Day 
23: Glut~0.44 mm vs. UnXL~.47 mm, p<0.999). 
Histological and Viability Staining 
Histological examination was used to assess the distribu- 5 
tion of cells and matrix proteins throughout the constructs 
and to evaluate the levels of integrationbetween the layers of 
the CSHs. H&E staining revealed that the support sleeves 
could be easily distinguished from the cell seeded sections 
at both the eight and twenty-three day time points. Sleeves 10 
treated with glutaraldehyde crosslinking presented a vivid 
red while uncrosslinked sleeves were stained a bright, but 
less intense, pink. Only faint staining of the reconstituted 
collagen was observed in the cell seeded layers. While the 
majority of cells were localized about the outer surface of 15 
the construct, regions of cell infiltration into the sleeve 
supports were observed indicating that integration had 
started to occur. 
Live-dead examination of the CSHs showed that incor-
poration of a support sleeve had no noticeable effect on cell 20 
viability in cell seeded layer. Cells tended to migrate/ 
proliferate on the outer construct surface as the nutrient 
supply was provided from the media surrounding the con-
structs. Consequently, few cells were found on the sleeve 
supports. Cells found on uncrosslinked sleeves tended to 25 
present green indicating viability while many of the cells 
found on glutaraldehyde crosslinked sleeves were stained 
red indicating cell death. All constructs exhibited greater 
than 95% overall cell viabilities. 
30 
Endothelial Cell Seeding 
40 
The linear moduli of CSH exhibited similar increases 
versus the unreinforced controls. After eight days of static 
culturing, the linear moduli of uncrosslinked and glutaral-
dehyde treated CSHs were 6.2-fold (p<0.0001) and 163-fold 
(p<0.0001) higher, respectively, than in the control con-
structs. After twenty-three days of culturing, the modulus 
parameters were 16.8-fold (p<0.0001) and 156-fold 
(p<0.0001) higher in uncrosslinked and glutaraldehyde 
treated CSHs, respectively, than in control constructs. 
Crosslinking the CSHs created 26.1-fold (p<0.0001) and 
9.3-fold (p<0.0001) higher linear moduli compared to 
untreated CSHs at days eight and twenty-three, respectively. 
Clearly, the use of a CSH approach in both the uncrosslinked 
and crosslinked forms improved the mechanical perfor-
mance of vascular constructs. Additionally, these results 
suggested that these benefits may persist beyond the three 
week time points examined in this study. 
As described previously, the areas under the stress-strain 
curves were used to give an idea of the degree of toughness 
in different construct samples. The energy required to bring 
a construct to the point of yielding was 11.0-fold (p<0.0001) 
and 21.7-fold (p<0.0001) higher in uncrosslinked and glu-
taraldehyde treated CSHs than in control constructs, respec-
tively, after eight days of culture. Similarly, this energy was 
14.9-fold (p<0.0001) and 40.4-fold (p<0.0001) higher after 
twenty-three days of culture. Glutaraldehyde treatment of 
the CSHs created a 2.0-fold (p<0.76) and 2.7-fold (p<0.23) 
in the mean observed yield energy parameters at days eight 
and twenty-three, respectively. 
After eight days of culture, the energy required to bring 
samples to failure was 6.8-fold (p<0.0001) and 7.4-fold 
(p<0.0001) higher in uncrosslinked and glutaraldehyde 
treated CSHs than in collagen controls, respectively. These 
values were 13.4-fold (p<0.0001) and 23.1-fold (p<0.0001) 
Endothelial cell seeding studies were performed to inves-
tigate whether these cells would adhere to the CSH lumens. 
Endothelial cells seed well onto the support sleeves. In the 
uncrosslinked samples, protruding cell membrane exten-
sions could be clearly visualized indicating that the cells 
were healthy and fully spread across the surface. While the 
endothelial cells seeded on glutaraldehyde treated sleeves 
continued to appear healthy, their membrane protrusions 
were not as apparent as in the UnXL sleeves. This could 
have been due in part to signal loss in the background noise 
created in the glutaraldehyde crosslinking process. 
35 higher after twenty-three days of culture. Glutaraldehyde 
treatment of the CSHs created no change in the failure 
energy parameters at either day eight (p<0.999) or day 
twenty-three (p<0.83). 
Uniaxial Tensile Testing 
The CSH approach dramatically alters the mechanical 
behaviors of reconstituted collagen grafts. While typical 
stress-strain profiles of all construct types displayed the 
characteristic non-linear toe regions followed by a quasi-
linear strain regime which is typical of native arteries and 
other biological tissues (Fung 1993 ), the degree of strain and 
loading levels were markedly different for the different 
construct types. Furthermore, while the UnXL CSHs and 
unreinforced control constructs experienced substantial 
yielding and plastic deformation, Glut CSHs were highly 
linear (R2 =0.999) up to the point of catastrophic failure. 
The ratios of failure to yield energies indicated that these 
40 constructs experienced vary different modes of failure. The 
energy ratio of uncrosslinked CSHs was 1.86 and 1.78 at 
days eight and twenty-three, respectively. With glutaralde-
hyde treatment, the ratio dropped to 1.02 (p<0.09 vs. UnXL 
CSH) and 1.10 (p<0.02 vs. UnXL CSH) at the two time 
45 points indicating that the crosslinked constructs failed 
abruptly with essentially negligible plastic deformation. 
Collagen control constructs, on the other hand, had rela-
tively high energy ratios-2.95 and 1.93 at days eight and 
twenty-three-indicating that large degrees of plastic defor-
5o mation took place prior to ultimate failure. These values 
were statistically different from the glutaraldehyde treated 
CSHs at both time points (8 Day~p<0.0001, 23 
Day~p<0.007) and from the UnXL CSHs after eight days 
(p<0.03) but not twenty-three days (p<0.99). There were no 
55 statistical differences observed with variations in the cultur-
ing duration of Glut CSHs (p<0.999) or UnXL CSHs 
(p<0.9995). The energy ratios in the unreinforced constructs, 
however, dropped from day eight to day twenty-three 
The ultimate stress parameters of the constructs under-
score the differences of the stress-strain profiles. After eight 
days of culture, the peak stresses of uncrosslinked and Glut 
CSHs were 8.9-fold (p<0.0001) and 49.3-fold (p<0.0001) 
higher, respectively, than in the control constructs. These 60 
differences increased to 11.0-fold (UnXL, p<0.0001) and 
65.2-fold (Glut, p<0.0001) fold by day twenty-three relative 
(p<0.005). 
Viscoelastic Testing 
While data from the uniaxial tensile testing clearly 
showed that dehydrating a collagen gel to form a CSH can 
augmented the overall mechanical strengths of TE vascular 
grafts, they were unable to provide information pertaining to 
the viscoelastic natures of the constructs. Creep and step-
wise stress relaxation were performed as static viscoelastic 
to the day twenty-three control as the cells continued to 
compact and remodel the constructs. Furthermore, Glut 
CSHs were 5.5-fold (p<0.001) and 5.9-fold (p<0.0001) 65 
higher than uncrosslinked CSHs at days eight and twenty-
three, respectively. 
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tests to characterize these viscous and elastic properties. In 
the creep testing experiments, the applied mechanical load 
was set equal to one third of the estimated ultimate tensile 
stress of each construct. In the stepwise stress relaxation 
experiments, five discrete strain displacements were intro- 5 
duced to each sample at six minute intervals. Burger's four 
element mechanical model was fit to the data and used to 
elicit quantitative viscoelastic parameters. 
42 
vs. UnXL CSH) when the support sleeves were treated with 
glutaraldehyde. Length of time in culture did not effect any 
of the Burger's model parameters. 
As 11 1 increases towards infinity, the constructs exhibit 
less and less sustained strain until Burger's viscoelastic 
model is eventually reduced to the model for a Standard 
Viscoelastic Solid. In maintaining proper vascular function, 
it is necessary to restrict the time-dependent creep behaviors 
to the short-term, recoverable domains. If the 11 1 viscosity As seen in the uniaxial tensile tests, control constructs 
without a collagen reinforcement sleeve were more suscep-
tible to larger degrees of instantaneous strain than either the 
uncrosslinked or glutaraldehyde treated CSHs. As time 
passed and the transient behaviors decayed, strain in the 
unreinforced control constructs settled into a constant defor-
mation rate which left unchecked eventually resulted in 
construct failure. Uncrosslinked CSHs exhibited some 
instantaneous deformation and a transient decay, but there 
was a marked reduction in the level of long term strain. 
Glutaraldehyde treated CHSs exhibited negligible instanta-
neous deformation and transient decays which were unable 
to be resolved on the observation time scales. Likewise, 
long-term strain behavior was essentially nonexistent. 
10 coefficient is too low, the construct will behave as a vis-
coelastic fluid, form aneurisms, and rupture upon implanta-
tion. 
Stress relaxation testing performed the inverse character-
ization as the creep analysis and was used to complement the 
15 creep analysis studies. Initial stress relaxation moduli, cal-
culated from the stress-strain relationships immediately fol-
lowing each step displacement, resulted from a combination 
of both the viscous and elastic elements of the constructs. 
The initial moduli jumped 9.3-fold (p<0.0007) and 13.4-fold 
The creep stress-strain data was fit to Burger's four 
element viscoelastic model. This allowed the observations 
perceived from the creep profiles to be expressed quantita-
tively. The elasticity parameter R1 defined by the instanta-
neous deformations caused by the introduction of a step load 
became larger when the constructs were combined with 
uncrosslinked support sleeves and cultured for eight ( 4,200 
Pa vs. 184,000 Pa, 43.8-fold increase, p<0.05) and twenty-
three days (12,700 Pa vs. 230,000 Pa, 18.1-fold increase, 
p<0.04). This rise continued to 36.5 MPa (8,700-fold 
increase, p<0.0001 vs. control; 199-fold increase, p<0.003 
20 (p<0.0001) when unreinforced collagen-based control con-
structs were combined with an uncrosslinked support sleeve 
for eight and twenty-three days of culture. These values 
increased again (8 Days: 55.3-fold, p<0.0001 vs. Control; 
5.9-fold, p<0.0003 vs. UnXL CSH; 23 Days: 107-fold, 
25 p<0.0001 vs. Control; 8.0-fold, p<0.0001 vs. UnXL CSH) 
when the CSH support sleeves were treated with glutaral-
dehyde. 
The relaxed stress relaxation moduli were defined by the 
stress-strain relationships six minutes after each step dis-
vs. UnXL CSH) at day eight and 2,620 MPa (206,000-fold 
increase, p<0.43 vs. control; 11,400-fold increase, p<0.43 
vs. UnXL CSH) at day twenty-three when the support 
sleeves were treated with glutaraldehyde. Large p-values at 
day twenty-three were caused by large variance in the Glut 
CSH data. 
30 placement-just before the introduction of the subsequent 
strain jump. By this time the transient effects of the mate-
rial's viscous elements were assumed to have decayed away 
leaving only the elastic components to bear the loads. The 
relaxed moduli of uncrosslinked CSHs were 18.8-fold 
35 (p<0.0002) and 30.5-fold (p<0.0001) higher than unrein-
forced control constructs after eight and twenty-three days 
of culturing. Likewise, the moduli were higher in glutaral-
dehyde treated CSHs than in the control constructs (8 Days: 
214-fold increase, p<0.0001 vs. Control; 11.4-fold increase, 
40 p<0.0001 vs. UnXL CSH; 23 Days: 461-fold increase, 
p<0.0001 vs. Control; 15.1-fold increase, p<0.0001 vs. 
UnXL CSH). 
Similarly, the elasticity parameter R2 and viscosity coef-
ficient 11 2 which defined the transient creep domain fre-
quently exhibited statistically significant rises when col-
lagen constructs were combined with uncrosslinked 
collagen support sleeves (R2 : 8 Days~12.l-fold increase, 
p<0.005; 23 Days~21.0-fold increase, p<0.02; 11 2 : 8 
Days~28.1-fold increase, p<0.001; 23 Days~27.8-fold 
increase, p<0.28). The same was true with glutaraldehyde 
treated CSHs (R2 : 8 Days~235-fold increase, p<0.001 vs. 
Control; 19.4-fold increase, p<0.003 vs. UnXL CSH; 23 
Days~249-fold increase, p<0.19 vs. Control; 11.9-fold 50 
increase, p<0.22 vs. UnXL CSH; 11 2 : 8 Days~35.0-fold 
increase, p<0.001 vs. Control; 1.25-fold increase, p<0.47 vs. 
UnXL CSH; 23 Days~89.1-fold increase, p<0.14 vs. Con-
trol; 3.21-fold increase, p<0.31 vs. UnXL CSH). These three 
parameters are important in that they describe the short-term 55 
compliance behaviors that take place with the pressure 
surges as blood flow is pumped through the construct. 
Ratios of the two stress relaxation moduli were used to 
identify the percentage of the mechanical strength in each 
45 construct which resulted from the viscous natures and from 
The final viscosity coefficient 11 1 was representative of the 
unrecoverable, long-term strain behavior. The values 
jumped 137-fold (p<0.006) and 34.3-fold (p<0.1 1) when 60 
unreinforced collagen-based control constructs were com-
bined with an uncrosslinked support sleeve and cultured for 
eight and twenty-three days, respectively. Again, the rise 
from control construct levels continued to increase to (Day 
8: 53,900-fold increase, p<0.08 vs. Control; 394-fold 65 
increase, p<0.19 vs. UnXL CSH; Day 23: 18,900-fold 
increase, p<0.001 vs. Control; 552-fold increase, p<0.001 
the elastic natures of the materials. The high initial to relaxed 
moduli ratios of the unreinforced collagen constructs indi-
cated that a majority of their resistance to deformation was 
the result of their highly viscous fluid-like natures. In 
glutaraldehyde crosslinked CSHs, these ratios were 1.45 
(p<0.006 vs. Control) and 1.37 (p<0.0001 vs. Control) for 
the two culturing time points investigated indicating that the 
materials were dominated by their elastic properties. The 
intermediate ratio values for the uncrosslinked CSHs 
revealed that they had viscoelastic properties between the 
unreinforced controls and the chemically treated CSHs (2.94 
at 8 Days: p<0.0005 vs. Control, p<0.0002 vs. Glut CSH; 
2.74 at 23 Days: p<0.0001 vs. Control, p<0.0002 vs. Glut 
CSH). 
As in the creep analysis, the stress-strain data from the 
stress relaxation experiments could be expressed using 
mathematical descriptions such as the Burger's viscoelastic 
model. The four elastic parameters and coefficients of vis-
cosity for the stepwise stress relaxation tests mirrored the 
trends seen in the creep investigations. After eight and 
twenty-three days of culturing, R1 parameters rose 6.7-fold 
(p<0.03) and 13.1-fold (p<0.0001) when unreinforced con-
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structs were combined with uncrosslinked support sleeves. 
When the sleeves were crosslinked, these parameters exhib-
ited an additional increases (Day 8: 24.0-fold, p<0.0001 vs. 
Control; 3.6-fold, p<0.005 vs. UnXL CSH; Day 23: 65.5-
fold, p<0.0001 vs. Control; 5.0-fold, p<0.005 vs. UnXL 5 
CSH). Similarly, R2 and 11 2 parameters rose when control 
constructs were combined with uncrosslinked CSH (R2 : 8 
Days~12.4-fold increase, p<0.02; 23 Days~19.9-fold 
increase, p<0.0003; 11 2 : 8 Days~l0.9-fold increase, 
p<0.004; 23 Days~21.2-fold increase, p<0.0001). The same 10 
was true with glutaraldehyde treated CSHs (R2 : 8 
Days~193-fold increase, p<0.0001 vs. Control; 15.6-fold 
increase, p<0.0003 vs. UnXL CSH; 23 Days~743-fold 
increase, p<0.0001 vs. Control; 37.3-fold increase, 
p<0.0001 vs. UnXL CSH; 11 2 : 8 Days~1080-fold increase, 15 
p<0.0001 vs. Control; 98.5-fold increase, p<0.0001 vs. 
UnXL CSH; 23 Days~1880-fold increase, p<0.0001 vs. 
Control; 88.5-fold increase, p<0.000 1 vs. UnXL CSH). 
When the long-term relaxation parameter 11 1 was investi-
gated, uncrosslinked CSHs increased 31.5-fold (p<0.004) 20 
and 49.6-fold (p<0.0001) versus unreinforced controls at 
days eight and twenty-three, respectively. Crosslinking 
induced an additional increase of the 11 1 coefficient (8 Days: 
3,920-fold, p<0.0001 vs. Control; 124-fold, p<0.0001 vs. 
UnXL CSH; 23 Days: 3,880-fold, p<0.0001 vs. Control; 25 
78.2-fold, p<0.0001 vs. UnXL CSH). As in the creep experi-
ments, time of culture did not play a significant role in 
affecting the Burger's model parameters. 
Burst Pressure Data 
Immediately following the construction of acellular 
30 
sleeves, burst analysis revealed that the supports all exhib-
ited relatively high peak pressures. Glutaraldehyde treat-
ment manifested in a 40% additional increase in burst 
strength (Glut~877 mmHg vs. UnXL~623 mmHg, 
35 
p<0.0001). When the UnXL acellular supports were incu-
bated in tissue culture media at 37° C. for eight days, the 
peak pressures of the sleeves dropped to 163 mmHg, or 26% 
of their original values (p<0.0001). The deterioration of 
acellular sleeves treated with glutaraldehyde was not nearly 
as drastic-peak pressures measured at 787 mmHg (90% of 
40 
Day 0 values, p<0.35) after eight days of culture. 
After eight days of culture, uncrosslinked support sleeves 
that were combined with cell-seeded layers to form CSHs 
demonstrated burst strengths that were significantly higher 
45 
than in the unsupported control constructs (p<0.001) as 
expected, but the peak pressure dropped even further. Fall-
ing to 99 mmHg, the UnXL CSHs were only 60% as strong 
as UnXL acellular supports which had been cultured for 
eight days (p<0.02) and only 16% as strong as UnXL 
50 
acellular supports that had not been exposed to culture 
media for eight days (p<0.0001). 
Again, the loss of strength with time was less pronounced 
if glutaraldehyde crosslinking was employed. The decrease 
of peak pressure in Glut CSHs cultured for eight days (649 
55 
mmHg) did not reach statistical significance compared to XL 
acellular supports cultured for the same duration ( <0.29) or 
XL acellular support sleeves that had not been exposed to 
culture media ( <0.06). The changes of the burst pressures 
ofacellular sleeves with time indicated the presence of non 
60 
specific, acellular modes of degradation. The relation of the 
strengths of acellular sleeves and of CSHs after eight days 
indicated the presence of cell-mediated modes of degrada-
tion as well. 
44 
cal strengths and elasticity of the constructs. TE constructs 
fabricated from fibrin and fibrin-collagen mixes were ana-
lyzed using gel compaction measurements, histological 
staining, and mechanical testing. The results described in 
this section correspond to experiments conducted on tubular 
constructs seeded with RASMs fabricated from human 
fibrinogen and/or Type I rat collagen. All constructs were 
cultured statically in an unconstrained fashion on silicon 
sleeves for six days prior to analysis. 
In conducting the analysis on the fibrin-based construct 
experiments, it was noticed that the batch-to-batch variabil-
ity between different sample preparations resulted in a 
statistically significant impact on many of the observations 
investigated. Since many of the changes between the treat-
ments used were subtle, a two-way ANOVA with blocking 
was used to evaluate the data to avoid missing statistically 
relevant changes which might have otherwise been masked. 
Gel Compaction Data 
During the initial forty-eight hours following their fabri-
cation, collagen-based, fibrin-based, and collagen/fibrin 
constructs all compacted rapidly. Although the ends of some 
samples exhibited slight irregularities, the three construct 
types compacted uniformly across the mandrel. Constructs 
containing fibrin exhibited increased compaction compared 
to their collagen-based counterparts. After six days of cul-
ture, fibrin constructs occupied only 52% of the volume of 
the collagen constructs (Fibrin~6.8% vs. Collagen~13.1%, 
p<0.0001). Gel compaction of the fibrin/collagen mixes 
were statistically dissimilar from either the pure fibrin or 
pure collagen constructs (Mix~9.7% vs. Collagen~13.1%, 
p<0.0003; Mix~9.7% vs. Fibrin~6.8%, p<0.002). 
The differences in matrix remodeling had a greater impact 
on wall thickness than on the lengths of the constructs. The 
changes in wall thicknesses mirrored the overall compaction 
trends, with the fibrin constructs and the fibrin/collagen 
mixes reducing to 50% and 71 % of the thickness of collagen 
constructs, respectively (Fibrin~0.523 mm vs. 
Collagen~l .05 mm, p<0.0001; Mix~.75 mm vs. Collagen, 
p<0.0002; Mix vs. Fibrin, p<0.002). After the culturing 
period, the collagen and fibrin/collagen mixes were lightly 
adhered to the silicon on the mandrel. While the bonding 
provided enough resiliency for dynamic conditioning and 
other mechanical manipulations, it did not present difficulty 
when removing the constructs from the mandrels. Fibrin 
constructs, on the other hand, formed tight adhesions with 
the silicon and were difficult to detach without damaging the 
samples. 
Histology 
Some histological H&E staining of collagen and fibrin-
based vascular grafts was performed by Christopher Cum-
mings. The matrix of constructs fabricated from reconsti-
tuted collagen appeared markedly different than the matrix 
of constructs fabricated from fibrin. While the matrix in 
collagen-based resembled that of similar constructs 
described previously, the fibrin-based constructs consisted 
of thicker fibers which were organized into "spiderweb" 
shaped structures. Large voids could be seen between the 
fibers of the fibrin gels. The fibrin/collagen mixes possessed 
properties of both the collagen and fibrin-based constructs. 
Although the samples discussed in this section were con-
structed using bovine Type I collagen (ICN) instead of rat 
tail collagen, the fabrication processes and culturing condi-
tions were equivalent to the other fibrin-based experiments. 
Fibrin-Based Constructs 65 Uniaxial Tensile Test Data 
Fibrin was investigated as a collagen substitute in the 
vascular grafts ECM in an attempt to improve the mechani-
Fibrin-based constructs possessed different characteristic 
stress-strain profiles than the collagen-based constructs and 
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fibrin/collagen mixes. They exhibited larger degrees of 
strain prior to imparting resistance to mechanical deforma-
tion. Following this extended "toe-region", the fibrin con-
structs demonstrated essentially linear stress-strain behavior 
(R2~.99) up to the point of failure with little to no yielding 
phenomena. 
Fibrin-based constructs exhibited a 3.5-fold increase in 
ultimate stress compared to collagen-based constructs 
(Fibrin~18.5 kPa vs. Collagen~5.3 kPa, p<0.0008) and a 
1.4-fold increase compared to fibrin/collagen mixes (Fibrin 10 
vs. Mix~12.9 kPa, p<0.13). A comparison between the 
collagen-based and fibrin/collagen mixed constructs 
revealed a 2.4-fold increase in tensile strength when fibrin 
was incorporated (Mix vs. Collagen, p<0.04). 
46 
The elasticity parameter R1 defined by the instantaneous 
strain jump at the onset of the creep experiment was highest 
in the collagen-fibrin mix (1.4-fold increase, p<0.14 vs. 
Fibrin; 1.7-fold increase, p<0.03 vs. Collagen). Similar to 
the extended "toe regions" seen in the uniaxial tensile data, 
the fibrin-based constructs demonstrated large degrees of 
deformation as the loads were introduced. This manifested 
in reduced R1 elasticity parameters which were statistically 
equivalent to collagen-based constructs. 
The elasticity modulus R2 and coefficient of viscosity 11 2 
which defined the transient region of the creep strain profile 
were highest in fibrin-based constructs (R2 : 3.9-fold 
increase, p<0.0001 vs. Collagen; 2.8-fold increase, p<0.002 
vs. Mix; 11 2 : 2.9-fold increase, p<0.02 vs. Collagen; 2.5-fold 
While the use of fibrin had substantial impact on the 
ultimate stresses of the various constructs, the resulting 
linear moduli were relatively unaffected. The linear moduli 
15 increase, p<0.05 vs. Mix). This agreed with the shortened 
time scales needed for the fibrin-based constructs to rapidly 
relax to their "steady-state" creep domain. Both the R2 and 
11 2 parameters were statistically indistinguishable between of the fibrin-based, collagen-based, and fibrin/collagen 
mixed constructs were statistically identical with mean 
values of 18.6 kPa, 21.0 kPa, and 21.5 kPa respectively 20 
(Fibrin vs. Collagen, p<0.85; Fibrin vs. Mix, p<0.78; Mix 
vs. Collagen, p<0.995). 
the collagen-based and mixed matrix constructs. 
The coefficient of viscosity 11 1 , the parameter responsible 
for long-term, or "steady state", creep behavior, was also 
slightly higher in fibrin-based samples than in the other 
materials (4.8-fold increase, p<0.0006 vs. Collagen; 2.5-fold 
increase, p<0.006 vs. Mix). This was seen in the decreased 
The work required for the tensile testing was obtained by 
integrating the area under the stress-strain curves. Observed 
mean yield energies were 3.6-fold larger for fibrin-based 
constructs than collagen-based constructs (Fibrin~0.063 
ml/mm vs. Collagen~0.18 ml/mm, p<0.015) and 2.8-fold 
larger for fibrin/collagen mixes than collagen-based con-
structs (Mix~.049 ml/mm vs. Collagen, p<0.083). 
Observed mean failure energies were 1.26-fold larger for 
fibrin-based constructs than collagen-based constructs 
(Fibrin~0.066 ml/mm vs. Collagen~0.052 ml/mm, p<0.57) 
and 1.41-fold larger for fibrin/collagen mixes than collagen-
based constructs (Mix~0.074 ml/mm vs. Collagen, p<0.27). 
25 rates of deformation that occurred at times long after the 
introduction of the creep load. Constructs containing a 50-50 
mix of collagen and fibrin did not possess higher 11 1 coef-
ficients of viscosity compared to collagen-based samples 
(p<0.44) indicating that combinations of ECM components 
30 did not affect the resultant gels as much as pure fibrin 
compositions. 
Example 10 
The ratios of the energy parameters revealed that the 
matrix compositions of the constructs affected their failure 
behaviors. Collagen-based constructs possessed high yield 
35 Mechanical Testing Methods 
to failure energy ratios compared to fibrin-based (3.0-fold 
increase, p<0.0001) and mixed constructs (2.2-fold higher, 
p<0.0003). Mixed constructs possessed higher ratios than 40 
fibrin-based constructs on average but were not significantly 
different statistically (1.4-fold higher, p<0.42). As in the 
glutaraldehyde treated CSHs described previously, the 
fibrin-based constructs exhibited negligible plastic deforma-
tion as evidenced by their essentially equivalent yield and 45 
failure energy parameters. 
Creep Viscoelastic Analysis 
As in the previous systems studied, mechanical charac-
terization of the fibrin-based constructs was not limited to 50 
uniaxial tensile testing. Creep analysis was performed to 
obtain initial data describing changes in viscoelastic behav-
iors with alternative extracellular matrix materials. In gen-
eral, the increased strengths of constructs fabricated exclu-
sively from fibrin and from fibrin-collagen mixes translated 55 
into decreased strain deformations under the loads in the 
creep analysis. 
Ring Testing Apparatus 
The mechanical properties of the cell-seeded tubular 
constructs were resolved using a ring testing apparatus. The 
instrument was designed to operate in the low force loading 
ranges which are characteristic of the collagen-based con-
structs. The ring testing apparatus consisted of five major 
elements: the structural framework and test chamber, a force 
transducer load cell, a servo motor position controller, an 
image acquisition system, and a data acquisition system. The 
steel framework structure stabilized the set-up and ensured 
a stationary test environment. A circular test chamber was 
fitted with watertight observation windows in both the front 
and back to provide a means of capturing sample images 
during testing. Samples were loaded into the chamber 
through a 1.5" diameter entrance port at the top of the 
chamber. The lower hook was connected to a DCI-CP3-50-
01 Mini™ linear position table (DCI Design Components, 
Inc., Fayetteville, Ga.) via a brass shaft which ran through an 
a-ring orifice in the bottom of the test chamber. The linear 
position table had a five inch lead screw travel range and a 
30 pound payload capacity which provided 0.1 inches of 
travel per revolution and was rated with a position accuracy 
of ±0.0005 inches. Limit sensors located at the boundaries of 
The stress-strain data of the three construct types were 
modeled using Burger's four parameter mechanical analog. 
The fits were typically very accurate with average param-
eters of 0.958, 0.964, and 0.970 for the fibrin-based, col-
lagen-based, and fibrin/collagen mixed constructs, respec-
tively. Average parameters of elasticity and coefficients of 
viscosity exhibited somewhat sizable deviations due in part 
60 the position table prevented damage from accidental over-
to the batch to batch variability that was observed. As 65 
described previously, a two-way ANOVA with blocking was 
employed to isolate the effects of ECM components. 
extension. 
The upper hook in the test chamber was threaded into a 
GSO series precision load cell (Transducer Techniques, 
Temecula, Calif.) with either a 30 or 150 gram loading 
range. The signal from the load cell transducer was trans-
mitted through an amplifier signal conditioner and tuned to 
a 0--5 volt DC analog signal output. The signal output was 
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directed to both a Pentium PC computer through a PCI-1200 
acquisition board and the servo motor position controller. 
The load cell transducer was calibrated manually at the start 
of each series of mechanical tests using a set of weights that 
spanned the range of the transducer. 
The integrated brushless DC servo motor (SmartMotor™ 
Model SM-2320, Animatics Corp., Santa Clara, Calif.) was 
used to drive the position table's lead screw. The motor 
tracked the amplified DC signal readings from the load cell 
using an analog input command function while communi- 10 
eating signal outputs to the PC computer through an RS-232 
port. Term™ terminal emulation software (Animatics Corp.) 
was utilized to generate and transmit commands to the 
memory module of the servo motor. 
Black and white digital images of the samples were 15 
captured during the mechanical tests using a V-1056SX 1/3" 
CCD camera (Marshall Electronics Inc., El Segundo, Calif.) 
connected to a Matox Meteor acquisition board (Matrox 
Electronic Systems Ltd., Montreal, Canada). Depending on 
the testing method used, the images were collected as 20 
640x480 pixel pictures in either a TIF file format or as a 
compilation of images in an AVI file format using Inspec-
tor™ 3.0 software (Matrox Electronic Systems Ltd.). Com-
pression of the AVI files was performed using a Microsoft 
file compression protocol to keep the size of the documents 25 
manageable. 
Force and position data were collected at 180 samples/sec 
through the PCI-1200 acquisition board using LabView™ 
software (National Instruments, Austin, Tex.). The 12-bit 
acquisition board contained 8 analog inputs, 2 analog out- 30 
puts, 24 digital input/output lines, and 3 counters/timers. 
Signal buffering of the load cell force data was performed 
digitally with a low-pass Butterworth filter using a 120 Hz 
sampling frequency and a 20 Hz cutoff frequency. Synchro-
nized readings of both signals were compiled into an 35 
Excel™ file format for subsequent data analysis. 
Sample Preparation 
48 
Using the Term™ command generator, the hooks were 
positioned adjacent to one another so that it was possible to 
thread them through the lumen of the ring specimens with 
surgical manipulators. The lower hook was then dropped 
downward until the hooks were approximately 2.5 mm apart 
from one another. Prior to testing, each specimen was 
preconditioned to remove stress history using the Precon-
ditioning.sm command program and the servo motor 
memory module. Preconditioning.sm provided the appropri-
ate directives to stretch each sample through three cyclic 0.2 
mm/sec loading sequences to approximately 20% of the 
strain at rupture. Force-displacement data were collected 
using the SampleFilter LabView™ file while images were 
captured into an AVI file ( 4 frames/sec) via Inspector™ 3.0. 
Following the removal of the stress history, the samples 
were stretched uniaxially to failure at a constant 0.2 mm/sec 
using the Stretch.sm preprogrammed command file. Sample 
images and force-displacement data were collected as 
described in the preconditioning loading stage until sample 
failure had occurred. Following the completion of each test 
run, the lower hook was returned to its original location for 
subsequent mechanical tests. 
Force-displacement readings were converted into stress-
strain data to assess the material properties of the tissue. 
Using the tab-delineated option, the data was opened into an 
Excel™ spreadsheet and converted from voltage readings to 
the appropriate units. The force-voltage relationship deter-
mined during the load cell calibration and the sample 
dimensions were inserted into the appropriate spaces of the 
spreadsheet to calculate Cauchy, or engineering stresses. 
Since it was not possible to reliably assess accurate cross-
sectional areas throughout the duration of the test, the 
stresses were normalized according to the pre-testing sample 
dimensions. Cauchy stresses were determined as follows: 
F{t) F{t) 
cr{t) =Ao= 2TW 
Equation 3.1. 
where a{ t} is the stress as a function of time, F { t} is the 
force as a function of time, A
0 
is the original cross-sectional 
area, T is the wall thickness, and W is the width of each ring 
sample. Since both construct walls are assessed at the same 
time in the ring specimen testing format, the dimensions are 
multiplied by a factor of two to obtain the cross-sectional 
area. 
Strain-displacement relationships for the ring samples 
were established from the collectedAVI files and the Inspec-
Tubular tissue constructs were removed from the cultur-
ing media and washed in PBS under gentle agitation. The 40 
constructs were than imaged via a color NTSC CCD camera 
connected to the Matrox Meteor image acquisition board to 
obtain dimensional information including degree of com-
paction and wall thickness. The rubber stoppers were 
removed from the glass mandrel and the constructs were 45 
loaded onto a ring slicing apparatus. Using a razor blade, the 
constructs were sliced into -5 mm sections. Four small black 
beads were affixed with a cyanoacrylate-based adhesive to 
one of the cut ends of each ring sample to provide local wall 
strain information. 
A digital caliper was used to determine the widths of each 
sample ring while wall thicknesses of each construct were 
calculated from analysis of digital images using Inspector™ 
3.0 software. Specimens were handled using surgical 
manipulators and care was taken in all steps to minimize 55 
incidental damage. Samples were stored in PBS at room 
temperature until ready to be tested. 
50 tor™ image analysis package. Using the BlobAnalysis func-
tion and the HookFinder script, bead and hook positions 
were determined at each frame from the onset of tensile 
deformation to just prior to the visual onset of failure. This 
set of data was transferred to an Excel™ spreadsheet, 
Uniaxial Tensile Test 
Uniaxial tensile tests were used to characterize the overall 60 
strengths of the TE vascular constructs. By stretching ring 
samples to failure at a constant strain rate, it was possible to 
educe circumferential tensile properties of the tubular con-
structs. This section describes the testing procedures, the 
processes used to convert the data into stress-strain relation- 65 
ships, and the methods employed to determine the reported 
mechanical parameters. 
converted to millimeters using a Creep_ Video_Data macro, 
and plotted to determine a linear mathematical relationship 
between the hooks and the beads on the left and right walls. 
The voltage displacement information in the original spread-
sheet was converted to Eularian strain data using the hook-





where E{ t} is the strain as a function of time, L{ t} is the 
distance between the hooks/beads as a function of time, and 




is the original distance between the hooks/beads. A 
distance of 4.01 nnn was typically used for the hooks of the 
standard tubular constructs to standardize the strain mea-
surements. The value corresponded to unstrained sample 
dimensions plus a 20% offset. The offset was necessary 
because of plastic deformations introduced during the pre-
conditioning runs. 
The mechanical data were plotted to obtain stress-strain 
relationships for each uniaxialy tested ring sample. Peak, or 
ultimate, stress ( amax or UTS) was identified as the maxi- 10 
mum stress data values for each sample. The linear modulus 
was calculated from the best fit slopes of the linear segments 
50 
moduli, and relaxation periods were evaluated from the data. 
Initial moduli were determined by best fit linear curves of 
the sample stresses immediately following each displace-
ment increment versus the corresponding hook strain at each 
point. Similarly, relaxed moduli were determined by best fit 
linear representations of the sample stresses six minutes 
after each step displacement versus the corresponding hook 
strain at each point. The relaxation periods were defined as 
the amount of time necessary for the loads in each sample to 
decay one half of the stress jumps associated with each step 
displacement increment. Stress relaxation profiles were also 
fit to linear mechanical models. of the stress-strain profiles. To standardize the moduli 
parameters, the linear segments were defined as the regions 
spanning 25-75% of the amax in each sample. The amount 15 Creep Tests 
of energy required to deform each sample was also calcu-
lated as an estimate of construct toughness. The yield energy 
was calculated by integrating the areas under the force-
displacement curves from the point of zero strain to the point 
where sample yielding was visually observed. The failure 20 
energy was calculated by integrating the areas from the point 
Static viscoelastic creep investigations were used to 
complement the stepwise stress relaxation analysis. Creep is 
the time-dependent change in strain following the introduc-
tion of a step alteration in stress. 
Once again, ring samples were prepared as previously 
described and loaded onto the hooks of the mechanical 
testing apparatus. Cross-sectional dimensions and calculated 
peak stress values from uniaxial tensile testing were 
of zero strain to the point where the stress on the sample had 
dropped to 50% of amax· Both yield and failure energies 
were normalized by the unstressed widths of each sample 
ring. 
Step-Stress Relaxation 
Stepwise stress relaxation was utilized as a static vis-
coelastic test method to assess the cell-seeded tubular con-
25 
employed to determine a target stress force values. Unless 
otherwise indicated, target values were aimed at one third of 
the sample's peak stress (a,arget"1;3 amax) These forces were 
converted to voltages using the load cell's calibration profile 
structs. By instantaneously stretching ring samples to set 30 
displacements and measuring the subsequent stress response 
as a function of time, it was possible to examine some of the 
viscoelastic mechanical behavior. 
Ring samples were prepared as previously described and 
loaded onto the hooks of the mechanical testing apparatus. 35 
Specimens were preloaded with the servo motor using the 
StressRelax.sm command file. During the first two minutes 
following the preload, force data was collected through the 
SampleFilter Labview™ file as described in the uniaxial 
tensile testing section. Manual recordings from a volt meter 40 
were taken every fifteen seconds during the subsequent four 
minutes. At the end of the sixth minute, a step displacement 
was introduced to the specimens using the Relax.sm servo 
motor connnand file. Force data was again acquisitioned 
through Labview™ for 120 seconds followed by four min- 45 
utes of manual recordings. Incremental step displacements 
were implemented at the 6'h, l2'h, 18'h, 24'h, and 30'h 
minutes. TIF file images were collected using Inspector™ 
after the preload and following every ensuing displacement. 
Hook displacements and bead locations were calculated 50 
directly from the TIF file images using Inspector™'s Blo-
bAnalysis function. This information was then converted 
into Eularian strain data using Equation 3.2. The preload 
force data was opened into an Excel™ spreadsheet using the 
tab-delineated format option. The colunms were shifted to 55 
the right and time values were inserted using the appropriate 
sampling rate such that time zero coincided with the occur-
rence of the peak force reading. Manually recorded time and 
force data points were also entered into the spreadsheet. The 
voltage force readings were converted to stress values using 60 
the pretest sample dimensions and the load cell force-
voltage calibration relationship. This procedure was 
repeated on the force files for the remaining step displace-
ments, and the data was compiled into a single spreadsheet 
and progrannned into the Creep.sm servo motor file. 
Following execution of the Preconditioning.sm preload-
ing regimes, the creep test procedures were implemented. 
Servo motor moved the lower hook downward at 1.6 
mm/sec until the target forces were realized. The hook 
velocities were then adjusted to 0.02 to 0.1 mm/sec down-
ward (depending upon the sample properties) if the force 
readings were lower than the target force or 0.0 to 0.005 
mm/sec upward if the force readings exceeded the target 
force. Thus it was possible to approximate a relatively 
constant force throughout the duration of the experiment. 
Specific fine tuning velocities were determined empirically 
for each sample type prior to testing. Force-displacement 
data were collected for the initial two minutes of each test 
using the SampleFilter Lab View™ file as described previ-
ously. For the first four minutes of each creep test, series of 
images were captured into AVI files at 4 frames/sec using 
Inspector™ 3.0 software. Subsequent images were collected 
at 0.2 frames/sec for the following sixteen minutes of 
testing. Tests were halted at the point of sample failure or 
after twenty minutes of creep. 
Strain displacement analysis was preformed on the AVI 
files using image analysis software. As previously described, 
the BlobAnalysis function and the HookFinder script were 
utilized to determine the locations of the hooks and beads at 
each point throughout the tests. The data was transferred to 
an Excel™ spreadsheet, converted to millimeters using the 
Creep_ Video_Data macro, and transformed into a time-
dependent strain relationship. As previously described, a 
4.01 nnn distance was typically used for the hooks of the 
standard tubular constructs to standardize the strain mea-
surements. Average force loads for each sample were deter-
mined from the SampleFilter force-displacement files and 
converted into Cauchy stresses using the unstressed sample 
to form a complete data set for each sample. 
As the sample stresses were plotted as a function of time, 
mechanical parameters including initial moduli, relaxed 
65 dimensions. Creep profiles were fit to linear mathematical 
models as later described to determine appropriate mechani-
cal parameters. 
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Example 11 
Mechanical Testing of Acellular Sleeves 
These samples require slow testing rates to accurately 
elucidate their stress-strain relationships. A commercial 
mechanical test apparatus (DDL, Inc., Eden Prairie, Minn.) 
was utilized to test the acellular support sleeves. 
DDL Mechanical Testing Apparatus 
A 650R DDL electromechanical testing system was uti-
lized to perform tensile tests on acellular sleeve supports. 
The test system was outfitted with a SM-200N load cell 
which was calibrated to 25 pounds according to the manu-
facture's protocol and connected to a pneumatic-driven 
upper grip through a universal connector. An environmental 
chamber designed to hold the samples in a saline during the 
mechanical testing was used in lieu of the lower grip. 
MtestWr software (DDL Inc.) was used to interface between 
the DDL apparatus and a Pentium PC. 
Sample Preparation 
Sleeves were briefly incubated in saline and cut along the 
long axis to remove them from the capillary tubes. This 
yielded relatively flat sheets approximately 38 mm in length 
and 9.5 mm in width. These sheets were further cut into test 
samples (-6 mmx9.5 mm) along either the circumferential 
or longitudinal orientation. The extreme edges of the sleeves 
were discarded because of physical defects introduced dur-
ing the drying on the capillary tubes. Disposable plastic 
grips (-7 mmx20 mm) were folded in half and affixed to 
each end of the test samples with a small amount of a 
cyanoacrylate-based adhesive such that 2 mm of each sleeve 
were held within the plastic grips. The precise dimensions of 
the test samples were measured using a digital caliper. Test 
samples were loaded into the environmental chamber of the 
test apparatus and the pneumatic actuator clamp was tight-
ened about the plastic grip and inflated to a pressure of 60 
psig. The environmental chamber was filled with PBS and 
samples were incubated in saline for approximately ten 
minutes prior to testing. 
Uniaxial Tensile Tests 
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temperature PBS under gentle agitation. After imaging each 
sample with a CCD camera, the extreme ends were removed 
with a razor blade. Samples were loaded into the burst 
chamber and sutured to the lure pegs which protruded in 
from the walls. The chamber was filled with PBS and sealed. 
Before each test, air was flushed from the system by running 
saline through the lumen of each construe. 
A syringe pump was used to infuse PBS into the sample 
at a constant flow rate of 4.0 ml/min while a Millar Mikro-tip 
10 catheter-type pressure transducer recorded local pressure 
changes near the lumens of the constructs. The pressure 
transducer was connected to a !Ox amplifier signal condi-
tioner which interfaced to a computer through a PCI-1200 
acquisition board using Lab View™ software. As previously 
15 described, digital video images were recorded into AVI 
series formats every 4 seconds throughout the tests to allow 
for pressure-diameter relationship calculations. The tests 
proceeded until the samples burst as evidenced by a rapid 
drop in the pressure readings. 
20 The data obtained from the burst pressure tests were 
analyzed in Excel™. A pressure-voltage relationship deter-
mined for the Millar pressure transducer over a 0 to 10 psig 
interval was used to convert the data to the appropriate units. 
The maximum pressure attained in each test was determined 
25 and defined as the peak, or burst pressure for the sample. The 
Inspector™ software line Measurement function was used to 
assess the outer diameters of the constructs throughout the 
tests. These measurements were converted to millimeters 
using the information from the preburst sample images. 
30 These measurements were inputted into the pressure data 
spreadsheet to obtain pressure-diameter correlations. Stiff-
ness parameters were estimated using the data spanning 
regions ranging from 25 to 75% of the peak pressure. 
35 Mechanical Models 
Creep and stress relaxation data were fit to either the 
standard viscoelastic solid (SVES) three element model or 
Burger's four element mechanical model to determine 
appropriate mechanical parameters. The following sections 
40 explicate the stress-strain relationships for the creep and 
stress relaxation tests as defined by the SVES and Burger's 
linear viscoelastic models. The methods used to solve these 
mathematical relationships are also described. Uniaxial tensile tests were used to gauge the strengths of 
the acellular support sleeves in both the circumferential and 
longitudinal orientations. Once the samples had been loaded 
into the testing chamber and allowed to equilibrate, three 45 
preconditioning cycles were performed to remove residual 
stress history and to eliminate slack introduced during the 
loading process. Samples were then stretched to failure at a 
constant rate of 3 mm/min while force-displacement data 
were collected at 60 samples/sec. The mechanical data were 50 
plotted to obtain stress-strain relationships for each sample 
tested. As in the cell-seeded constructs, ultimate stresses 
Standard Viscoelastic Solid (SVES) 
The constitutive equation for the SVES is a follows: 
Equation 3.3. 
where a{t} and E{t} are respectively the stress and strain 
as functions of time, R1 and R2 are elastic parameters, and 
ri is the coefficient of viscosity. In creep testing, samples are 
exposed to a step increase in stress at time zero. At times 
greater than zero, the stress is held constant, (a{t}=a
0
). 
When inputted into Equation 3.3, the strain as a function of 
time can be expressed as: 
(a max) were identified as the maximum stress data values for 
each sample. Linear moduli were calculated as the best fit 
slopes of the linear segments (spanning 25-75% of the amax) 55 
of the stress-strain profiles. 
Burst Pressure Testing 
Equation 3.4. 
The mechanical performance of some of the tubular 
constructs and acellular support sleeves were characterized 60 
through burst pressure assessment. In these tests, entire 
constructs were ligated into a burst pressure chamber, and 
inflated at a constant flow rate until the point of rupture. This 
section describes the testing procedure and the analysis 
methods used in the burst pressure tests. 65 In the stress relaxation tests, samples were exposed to step 
changes in strain (E
0
). When inputted into Equation 3.3, the 
stress relationship as a function of time can be expressed as: 
Following the specified culturing periods, constructs were 
removed from their growth media and washed in room 
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Equation 3.5. 
This model allows for instantaneous changes in both stres-
sand strain which are followed by decaying transition peri-
ods. The SVES is considered a viscoelastic solid because the 
54 
were run until acceptable solutions were obtained. Hook 
(overall) strain measurements were selected in favor of wall 
(local) strains due to the anomalous behaviors that fre-
quently accompanied the beads. Mechanical parameters 
were calculated for each sample and grouped together to 
perform statistical inferences on the samples. 
Example 12 
materials will continue to support a stress without deforma- 10 
tion after all the transients have died away. Characterization of Cell and Construct Functionality 
Burger's Viscoelastic Model 
In addition to appropriate mechanical behaviors, there are 
many other requirements that will affect the success of tissue 
engineered vascular grafts. Knowledge of cell proliferation, The constitutive equation for Burger's model is as fol-
lows: 
{} (
'71 '11 '12).{} '11'72 .. 1} .1} '11'72 .. {} Equation 3.6. CT t + - + - + - CT t +--CT t = f}IE t + -£ t 
R1 R1 R1 R1R2 R1 
15 viability, and matrix expression can help to ascertain the 
effects of various factors on cellular function. Similarly, 
information pertaining to ECM structure reorganization and 
gel compaction will help to link cellular function and 
culturing conditions back to construct functionality and 
mechanical behavior. 
20 
where a{t} and E{t} are respectively the stress and strain as 
a function of time, R1 and 11 1 are the elastic parameter and 
coefficient of viscosity for the Maxwell unit, and R2 and11 2 
are the elastic parameter and coefficient of viscosity for the 
Kelvin unit. In the analytical solution for creep where 25 
samples are exposed to a constant stress (0
0
) the strain 
functions of Equation 3.6 can be expressed as: 
<To <To <To [ (-R2t)] 10(t) = - +-t+- 1-exp --
R1 '11 R1 1/2 
Equation 3.7. 30 
In the analytical solution for stress relaxation tests where 
samples were exposed to step changes in strain (E
0
) stress in 35 
Equation 3.6 as a function of time can be expressed as: 
a{t} =E.}A [(K1-K2L2)exp(-L 1t)-(K1-K2L2)exp(~31 
L 2 t)] Equation 3.8. 
where: 
Construct Imaging and Dimensional Analysis 
Digital images of constructs were acquired at the end of 
each culturing period to observe macroscopic appearances 
and to perform dimensional analysis. A color NTSC CCD 
camera outfitted with a c-mount lens was used to capture 
images onto a PC computer through a digital acquisition 
board. Files were saved into a TIFF file format and analyzed 
using Inspector 3.0 software. Construct lengths and widths 
were determined in terms of pixels through three indepen-
dent measurements of each parameter. Pixels were then 
converted to standard units using a metric ruler that was 
imaged simultaneously with each construct. The volume of 
each construct (V) was computed using the following equa-
tion: 
( ") 2 2 V= 4 x(D0 -D;)XL 
Equation 3.9. 
40 where D0 was the outer diameter of the construct, D, was 
11 = '!_!_ + '!_!_ + '.!!._ 
R1 R1 R1 
the inner diameter of the construct, and L was the construct 
length. D
0 
and L were determined from the average of the 
parameter calculations while D, was assumed equal to the 
widths of the glass mandrel capillary tubes (or the silicone 
L1 = (11 -A) 
2h 
U1 +A) 
Li= ----v;- h = '71'72 R1R2 45 support sleeves in the case of the fibrin matrix studies). 
A = ~ 1[-4h K1 ='71 
K1 = '71'72 
R1 
50 
Like the SVES, Burger's model is capable of instanta-
neous stress-strain changes which are followed by transition 
periods. Unlike the SVES, Burger's model describes a 
viscoelastic fluid because stress relaxation loads will even-
tually decay to zero and sample will continue to deform 55 
indefinitely under applied stress loads. 
Mathematical Solutions 
Degree of construct compaction, reported as a percentage 
of original volume, was calculated using the following 
relationship: 
Compaction~( V!VoJx 100% Equation 3.10. 
where V 
0 
corresponded to the original volume of the 
construct and was calculated using the following equation: 
( ") 2 2 V0 = 4 x(ll.5 -D;)XL0 Equation 3.11. 
Hook data from viscoelastic tests were fitted to mechani-
cal models using Excel's Solver Add-In package. Best fit 
values for each parameter were determined by minimizing 
the sums of the square of the errors between the proposed 
models and the experimental data sets. Nonlinear Newtonian 
searches were conducted using quadratic estimates and 
central derivatives. Precision and convergence criteria were 
L
0 
corresponded to the original length of the constructs 
and was determined using the average of three independent 
60 measurements of the distances between the rubber stoppers 
on the mandrel. The initial outer diameters of the constructs 
set at lx10- 10 to ensure that the application ran until a 65 
high-quality fit was obtained. Initial parameter guesses were 
selected to minimize erroneous root solutions, and the fits 
were assumed equivalent to the inner diameters of the test 
tube molds (11.5 mm). Once again, D, was assumed equal to 
the widths of the glass mandrel capillary tubes. Average wall 
thickness of each construct was calculated as follows: 
Equation 3.12. 
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Cell Viability Assays 
Live-dead examinations were performed using a calcein-
AM/ethidium homodimer-1 stain (Molecular Probes, 
Eugene, Oreg.) to establish cell viability and distribution 
throughout the constructs. Samples were rinsed 3x10 min-
utes in buffered saline and incubated at room temperature in 
a calcein-ethidium ( 4 µM-4 µM, respectively) saline solution 
for 45 min. Following three subsequent 10 min washes to 
remove excess staining solution, the samples were imaged 
on a Zeiss LSM 510 confocal microscope (Carl Zeiss, Inc., 10 
Thornwood, N.Y.). As the calcein-AM crossed the cellular 
membranes, the molecule was cleaved by esterase activity 
within viable cells to elicit cytoplasmic green fluorescence. 
Ethidium homodimer-1, a membrane impermeant dye, 
labeled the nucleic acids of dead/membrane-compromised 15 
cells with red fluorescence. Cell viability was estimated 
roughly as a function of distance into both the construct and 
the sleeve support layers. 
56 
While the hydrogel nature of the collagen constructs com-
plicated the embedding and sectioning processes, satisfac-
tory tissue slices were able to be obtained with slight 
additional effort. The methods outlined in this section detail 
the sample preparation, embedding, sectioning, staining, and 
visualization techniques. 
Sample Preparation and Sectioning 
Following each culturing period, constructs were washed 
in buffered saline to remove residual media. Ring sections 
were then cut from each sample and immersed in an 
Accustain 10% formalin solution (Sigma). The fixed sec-
tions were placed in plastic processing/embedding cassettes 
and cycled through a Pathcentre Enclosed Tissue Processor 
(Shandon Scientific Limited, Pittsburgh, Pa.) to dehydrate 
the specimens. Table 3.3 outlines the steps involved in the 
tissue processing protocol. 
Once dehydrated, the samples were embedded in paraffin 
wax using a Histocentre 2 Tissue Embedding System (Shan-
DNA Assays 20 don Scientific Limited) and sectioned into 5-6 µm slices on 
a HM355S Rotary Microtome (Microm, Waldorf, Germany) 
using an automatic feed and a disposable knife. Samples 
were sectioned in planes both parallel and perpendicular to 
the long axis of the tubular construct. Tissue slices were 
Estimations of the total number of cells within constructs 
were made using a Hoechst DNA binding dye. Cultured 
constructs were washed 3x10 minutes in PBS (pH 7.4) and 
stored frozen (-20° C.) until ready to be analyzed. Construct 
samples were then digested in a 0.5 mg/ml proteinase K 
solution (50 mM Tris, 0.1 M EDTA, 0.2 M NaCl, pH 7.4, -1 
ml/M cells) containing 0.1 mg/ml sodium dodecyl sulfate 
(SDS) at 55° C. for 12 hours (Kim and Mooney 1998). The 
samples were passed through a 25-gauge syringe needle 
three times, inspected visually to ensure complete digestion, 30 
and centrifuged for 2 min at 2000 rpm (320 g) to remove 
large debris. Samples were then loaded in duplicate (10 
µI/well) into a 96-well black plate (VWR, Suwanee, Ga.) at 
I-fold, 4-fold, and 8-fold dilutions and combined with a 0.1 
µg/ml Hoechst-33258 dye solution (10 mM Tris, 1 mM 35 
EDTA Na2 .2H20, 0.2 M NaCl, pH 7.4, 200 µI/well). Fol-
lowing a 10--15 min incubation in the dark at room tem-
perature, samples were read on a Spectra Max Gemini plate 
reader (Molecular Devices, S=yvale, Calif.) at 25° C. 
using a 365 nm excitation wavelength and a 458 nm emis- 40 
sion wavelength. Standards created from calf-thymus DNA 
and known cell populations analyzed using the Coulter 
Multisizer were run in parallel to estimate the number of cell 
25 picked up from the knife using forceps and a paint brush and 
floated across the surface of a 45° C. water bath. The slices 
in each construct. 
Endothelial Cell Seeding 45 
Tubular constructs and acellular support sleeves were cut 
along the long axes and opened up such that their inner 
lumens were exposed. They were then embedded in a 3.5% 
agar gel in this configuration to provide a flat lumenal 
surface. Passage 4/5 human coronary endothelial cells 50 
(HCEC, Clonetics) were trypsinized and seeded onto the 
surfaces (25,000 cells/cm2 ) for one hour at 37° C. The 
constructs/sleeves were then covered with endothelial cell 
growth media (MCDB-131 culture media supplemented 
with 2 mM L-glutamine, 2 ng/ml basic human fibroblast 55 
growth factor (hFGF), 10 ng/ml human endothelial growth 
factor (hEGF), 2 ng/ml insulin-like growth factor-I (IGF-I), 
1 ng/ml vascular endothelial growth factor (VEGF), 1 µg/ml 
hydrocortisone, 50 µg/ml ascorbic acid, 5% FBS, 100 IU/ml 
penicillin, and 100 µg/ml streptomycin) and incubated for 12 60 
hours at 37° C. The HCEC were labeled with Cell Tracker 
Green CMFDA, 5-chloromethyl fluorescein (Molecular 
Probes) and imaged on a Zeiss LSM confocal microscope. 
Histology and Histochemistry 65 
Evaluation of matrix fiber structure and cell organization 
were performed using histology and immunohistochemistry. 
were then picked up onto Superfrost® Plus microscope 
slides (VWR, West Chester, Pa.) and dried at 45° C. for 2 
hours. Once on slides, tissue slices were stored at room 
temperature until ready for staining. 
TABLE 3.3 
Tissue Processing Procedure for Histological Sectioning. 
Step Procedure Duration Temperature 
Step 1 70% Alcohol 60 minutes Ambient 
Step 2 80% Alcohol 60 minutes Ambient 
Step 3-5 95% Alcohol 3 x 60 minutes Ambient 
Step 6-7 100% Alcohol 2 x 60 minutes Ambient 
Step 8 EtOH-Xylene 60 minutes Ambient 
Step 9-10 Xylene Substitute 2 x 60 minutes Ambient 
Step 11-13 Paraffin 3 x 45 minutes 60° C. 
Total -12 hrs 15 min 
TABLE 3.4 
H&E Staining Protocol. 
Step Procedure Duration 
Steps 1-3 Xylene Substitute 3 x 3 minutes 
Steps 4-6 100% Alcohol 3 x 30 seconds 
Step 7 80% Alcohol 30 seconds 
Step 8 Tap Water 1 minute 
Step 9 Hematoxylin 4 minutes 
Step 10 Tap Water 1 minute 
Step 11 Acid Alcohol 1 second 
Step 12 Tap Water 1 minute 
Step 13 Eosin Y 1.5 minutes 
Step 14 95% Alcohol 30 seconds 
Steps 15-17 100% Alcohol 3 x 30 seconds 
Steps 18-20 Xylene Substitute 3 x 30 seconds 
Total ~24 minutes 
Hematoxylin and Eosin Staining 
Sectioned slides were deparaflinized and stained with 
hematoxylin and Eosin Y (H&E) using methods adapted 
from Richard-Allan Scientific (Seliktar 2000) and Advanced 
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Tissue Sciences, Inc. (Saini 2001). A Varistain XY Auto-
matic Stainer (Shandon Scientific Limited) set at mild 
agitation was employed to provide reproducibility. The 
individual steps involved in the staining process are outlined 
in Table 3.4. Hematoxylin and Eosin Y reagents were 
obtained from Richard-Allan Scientific (Kalamazoo, Mich.). 
Acid alcohol refers to 0.5% acetic acid in 70% ethanol. All 
other reagents were obtained Shandon Scientific Limited. 
Following the last staining step, specimens were mounted 
and coverslipped with 24x40 mm No. 1 coverslips. Excess 
mounting media was wiped away with a cloth soaked in 
xylene substitute and the slides were placed in a fume hood 
for several hours to dry before microscopic examination. 
58 
Reverse-Transcriptase Polymerase Chain Reaction (RT-
PCR) 
Elastin message RNA gene transcripts were quantified 
through a competitive RT-PCR reaction with the BamHI/ 
EcoRII fragment of the v-erbB gene (Clontech) which had 
been modified to contain gene-specific primer sequences. 
These primer sequences were designed using a Primer 
Premier 4 software package (Clontech) to ensure high 
10 
template binding affinity and to minimize false priming, 
hairpin loops, and primer-dimerization. After PCR amplifi-
cation, the modified v-erbB fragment, or PCR mimic frag-
ment, was quantitated with a spectrophotometer at a 260 nm 
Verhoff Staining 
15 
Various techniques have been developed to identify elas-
wavelength and aliquoted into serial dilutions ranging from 
100 to 0.01 attomole/µL. The 9,306 Da oligomer sequence 
5'-CGG CGC CTT CCC CGC AGT TAC CTT T-3' was used 
tic fibers in tissues. Verhoff's iodine-ferric chloride hemo-
toxylin is one of the more popular methods and has been 
shown to elicit fairly reproducible results. Slides were 
deparaffinized and rehydrated as in the H&E staining pro-
20 
tocol. The slides were stained in an iodine-ferric hematoxy-
as the forward elastin primer. The 9,305 Da oligomer 
sequence 5'-ACA CAA CCC CTG GAA CCG CAG CAC 
C-3' was used as the reverse elastin primer. 
Cell monolayers and three dimensional cell-seeded tis-
sues were harvested for total RNA by disrupting the cell 
membranes with mechanical homogenization and RLT 
Buffer (Qiagen, Inc., Valencia, Calif.) containing ~-mercap­
toethanol. Samples were further homogenized by passing 
lin solution (American Master Tech Scientific, Lodi, Calif.) 
for 20 minutes until the sections were perfectly black. The 
sections were then differentiated in 2% aqueous ferric chlo-
ride solution until the elastic fibers presented black against 
a colorless background. The ferric chloride was rinsed off in 
tap water (-5 minutes), and samples were counterstained in 
Van Gieson's stain (American Master Tech Scientific). 
Specimens were then washed in tap water, dehydrated, 
mounted, and coverslipped as in the H&E staining protocol. 
25 the lysate through a 25-G syringe needle five to ten times. 
Immunostaining 
Structural organization of elastic fiber networks was also 
visualized via elastin immunostaining. Sections of con-
structs and tissue affixed to microscope slides were depar-
affinized and rehydrated as described in the H&E staining 
protocol. Slides were incubated in a 5% horse serum saline 
solution for 60 minutes to block non-specific binding. A 
solution of mouse monoclonal anti-elastin antibody (Sigma, 
BA-4) diluted 1 :50 in the horse serum blocking buffer was 
overlaid on top of each slide (-150 µl per slide). Slides were 
incubated at 37° C. in a humid environment for sixty 
minutes. Two saline washes followed by a 10 minute incu-
bation in blocking buffer and two additional saline rinses 
were used to remove unbound antibody. A solution of 
FITC-conjugated goat anti-mouse secondary antibody 
diluted 1 :50 in the horse serum blocking buffer was overlaid 
on top of each slide (-150 µl per slide). Again, two saline 
washes followed by a 10 minute incubation in blocking 
buffer and two additional saline rinses were used to remove 
unbound antibody. Slides were coverslipped using aqueous 
anti-fade mounting media and imaged using fluorescent 
microscopy. Images were collected within 24 hours to 
prevent signal loss. 
Microscopic Examination 
One volume of70% ethanol was added to the lysate and total 
RNA was isolated from each sample using Qiagen RNeasy 
columns and mini-kits. The samples were quantitated to 
assess the amounts of total RNA and tested for purity with 
30 a spectrophotometer at 260 nm and 280 nm wavelengths. 
Five micrograms of RNA from each sample were converted 
to cDNA with Avian Myeloblastosis Virus (AMY) reverse 
transcriptase (Promega, Madison, Wis.), purified with a 
phenol-chloroform extraction followed by an ethanol pre-
35 cipitation, and resuspended in 50 µl of RNase-free water. 
Competitive PCR reactions were run using equal volumes of 
sample cDNA and mimic fragment dilutions. Twenty-eight 
cycles (94° C., 30 sec dissociation; 63° C., 30 sec annealing; 
72° C., 65 sec extension) were repeated using Taq DNA 
40 polymerase (Fisher) in PCR Buffer B (Fisher) with 0.2 mM 
dNTP, 2 mM of both forward and reverse primers, and 2 mM 
magnesium. The PCR products were separated by agarose 
gel electrophoresis and visualized with an UV transillumi-
nator. Images of the DNA bands were captured with a CCD 
45 camera and quantitated using Gel-Pro Analyzer 3.0 soft-
ware. Tropoelastin cDNA concentrations were considered to 
be equivalent to mimic fragment when the band intensities 
of the PCR products were balanced. 
50 Immunoblotting 
Immunoblotting techniques were used to detect the pro-
duction of soluble elastin precursors. Concentrated samples 
were prepared from spent media and separated by molecular 
weight via SDS-polyacrylimide gel electrophoresis (SDS-
55 PAGE). Proteins were then transferred onto nitrocellulose 
paper and probed for elastin with the BA-4 monoclonal 
antibody (Sigma) using standard Western blotting methods. 
Examination of the stained histological sections was 
performed on a Zeiss Axiovert 200 microscope (Carl Zeiss, 
Inc.) using either a LD-A Plane 20x(0.30 NA) or a AChro-
plan 40x(0.65 NA) objective. Images were captured on a 
Kodak digital camera. Visualization of fluorescently labeled 60 
immunostained slides was accomplished on a Carl Zeiss 
LSM 510-model confocal microscope (Carl Zeiss, Inc.) 
using either a 1 Ox(0.25 NA, 6.5 mm WD), 20x(0.30 NA, 2.2 
mm WD), or 63xoil immersion (1.25 NA, 0.1 mm WD) 
objectives. Fluorescent samples were excited using Argon 65 
and HeNe lasers and images were collected using LSM 510 
Version 2.02 software and saved in a TIFF file format. 
Sample Preparation and Ammonium Sulfate Precipitation 
Spent media samples were separated into 1.7 ml aliquots 
in microcentrifuge tubes and combined with 30% ammo-
nium sulfate (w:v) (Sigma). Samples were vortexed, incu-
bated on ice overnight, and spun down at full speed (15,800 
g) for 15 minutes at 4 ° C. The supernatants were carefully 
removed, and the pellets were resuspended with 100 µl DI 
water. Like samples were repooled together, loaded into 
10,000 MWCO Slide-a-Lyzer dialysis cassettes (Pierce, 
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Rockford, Ill.), and dialyzed against DI water for 24 hrs at 
4° C. Following dialysis, samples were stored at -20° C. 
until ready for analysis. 
SDS-PAGE and Protein Transfer 
60 
described previously. The gels were removed from the 
electrophoresis apparatus and incubated in a colloidal Coo-
massie blue solution (BIO-RAD Laboratories) for 90 min-
utes followed by a 45-minute rinse in an acetic acid destain-
ing solution. The gels were then rinsed overnight in DI water 
and imaged with a CCD camera. 
It must be noted that, as used in this specification and the 
claims, the singular forms "a," "an," and "the" include plural 
referents unless the context clearly dictates otherwise. Thus, 
10 for example, reference to a vector composition containing 
"an agent" means molar quantities of such an agent. 
PAGE gels containing 5% stacking and 10% running 
acrylimide (BIO-RAD Laboratories, Hercules, Calif.) con-
centrations were constructed using standard fabrication pro-
tocols. Samples combined with loading buffer containing 
~-ME were heated at 90° C. for 3 minutes to remove 
secondary structural conformations and loaded into the gels 
(24 µI/lane). A mid-range molecular weight rainbow marker 
(BIO-RAD Laboratories) was used for molecular weight 
determination. The gels were run in an EC-140 gel electro-
phoresis box (E-C Apparatus Corporation, Holbrook, N.Y.) 
15 
at 0.4 amps for 60 minutes using a BIO-RAD Power Pak 
2000 power supply (BIO-RAD Laboratories). At the end of 
sixty minutes, bands from the molecular weight marker were 
distributed nicely throughout the length of the gel. When the 
blue rumiing dye passed through the bottom of the gel, the 
20 
system was taken down and the gels were processed for 
immunoblotting. 
Protein transfer from the PAGE gels to Hybond ECL 
nitrocellular transfer paper was performed in an EC-140 
Mini Blot Module (E-C Apparatus Corporation). Transfer 
25 
modules were constructed as described in the E-C Apparatus 
instructions manual using sandwiches containing layers of 
filter paper and Scotch Brite™ sponge pads. Transfers were 
performed at 80 volts for 45 minutes. At the end of the 
transfer, bright bands from the lower weight marker proteins 
30 
were visible on the nitrocellulose paper. Although the largest 
proteins may not have transferred completely, additional 
transfers resulted in the loss of smaller proteins through the 
nitrocellulose paper. Membranes were removed from the 
blotting apparatus and immediately placed in a 5% blocking 
35 
buffer containing 5% dehydrated non-fat milk (w:v) in Tris 
Buffered Saline-Tween 20 (Sigma). 
Immunoblotting and Antibody Incubations 
It is to be understood that this invention is not limited to 
the particular combinations, methods, and materials dis-
closed herein as such combinations, methods, and materials 
may vary somewhat. It is also to be understood that the 
terminology employed herein is used for the purpose of 
describing particular embodiments only and is not intended 
to be limiting. 
What is claimed is: 
1. A tubular construct suitable for implantation, compris-
ing, a biological support structure comprising a gel matrix 
admixed with a cellular composition comprising one or 
more types of cells and products of cells, and an intact 
elastin scaffold. 
2. The tubular construct of claim 1, wherein the gel matrix 
comprises collagen. 
3. The tubular construct of claim 1, wherein the gel matrix 
comprises fibrin. 
4. The tubular construct of claim 1, wherein the cellular 
composition comprises smooth muscle cells. 
5. The tubular construct of claim 1, wherein the cellular 
composition comprises altered or modified cells. 
6. The tubular construct of claim 1, wherein the cellular 
composition and the intact elastin scaffold are derived from 
the same species. 
7. A method of repair of soft tissue, comprising, implant-
ing a tubular construct suitable for implantation, comprising, 
a biological support structure comprising a gel matrix 
admixed with a cellular composition comprising one or Blocking was performed overnight at 4 ° C. under gentle 
agitation. The membranes were then covered with mono-
clonal anti-elastin mouse IgG antibody (Sigma, BA-4) 
which had been diluted 1:1,000 in a 2.5% non-fat milk TBS 
Tween blocking buffer at room temperature for 90 minutes. 
The membranes were washed 3x5 minutes in TBS-Tween 
and covered with the secondary HRP-conjugated anti-mouse 
antibody (1: 1,000 dilution) (Amersham Pharmacia Biotech) 
40 more types of cells and products of cells, and an intact 
elastin scaffold. 
8. The method of claim 7, wherein the gel matrix com-
prises collagen. 
9. The method of claim 7, wherein the gel matrix com-
45 prises fibrin. 
in 2.5% blocking buffer at room temperature for 90 minutes. 
Three five-minute TBS-Tween washes were performed to 
remove the unbound antibody, and the protein sides of the 
membranes were covered with an ECL-Plus chemilumines- 50 
cent solution (Amersham Pharmacia Biotech) for five min-
utes. At the end of the incubations, membrane papers were 
covered with plastic wrap and incubated with X-ray film 
(Kodak, Rochester, N.Y.) for 2 to 25 minutes. The film was 
processed and digitized using a 32-bit scanner. Images were 55 
saved as TIF files for data analysis. 
Cyanogen Bromide (CNBr) Digestion 
The degree of crosslinking in acellular sleeves was 
assessed using CNBr digestion. CNBr was added to 70% 
60 
formic acid (Sigma) to form a 10 mg/ml solution. Sections 
of sleeves weighing 1.5-2.5 mg were immersed in the 
solution at approximately a 1:90 (w:v) ratio and incubated 
for 24 hours at 4 ° C. under gentle agitation. Sham digestions 
were performed in 70% formic acid as controls. Following 
the digestion, the samples were centrifuged briefly to pellet 
undissolved matrix and run on a 10% SDS-PAGE gel as 
65 
10. The method of claim 7, wherein the cellular compo-
sition comprises smooth muscle cells. 
11. The method of claim 7, wherein the cellular compo-
sition comprises altered or modified cells. 
12. The method of claim 7, wherein the cellular compo-
sition and the intact elastin scaffold are derived from the 
same species. 
13. A method for determining activity of agents, compris-
ing, a) providing a tubular construct, comprising, a biologi-
cal support structure comprising a gel metrix admixed with 
a cellular composition comprising one or more types of cells 
and products of cells, and an intact elastin scaffold, b) adding 
at least one agent to the tubular construct and c) determining 
an effect on the tubular construct. 
14. The method of claim 13, wherein the gel matrix of the 
tubular construct comprises structural proteins collagen, 
fibrin, or elastin. 
15. The method of claim 13, wherein the cellular com-
position comprises altered or modified cells. 
* * * * * 
